Cyclopropyl carbinol derivatives

ABSTRACT

Aryl substituted diketones and keto-esters, useful as antiviral agents and insecticides, are prepared by reacting an arylalkyl or arylalkenyl iodide with a metal salt of the appropriate diketone or keto-ester.

United States Patent 1 1 Collins [4 1 Nov. 4, 1975 Related US. Application Data [63] Continuation-impart of Ser. No. 265,333, June 22,-

1972, Pat. NO. 3,829,475. a

[30] Foreign Application Priority Data June 18, 1973 United Kingdom 28793/73 [52] US. Cl 260/613 R; 260/520; 260/340.5; 260/521 R; 260/515 P; 260/592; 260/618 R; 260/618 D; 260/613 D; 260/650 R; 260/668 R; 260/476 R; 260/469; 260/621 R; 260/479 R; 260/558 R; 260/577; 260/556 AR; 260/586 R; 424/282; 424/308 [51] Int. Cl. C07C 43/20 [58] Field of Search 260/613 R, 618 D, 618 R, 260/613 D [56] References Cited UNlTED STATES PATENTS 2/19'72 Holan 260/613 R 2/1973 Schroeter 260/613 R Primary Examiner-Bernard Helfin Attorney, Agent, or Firm-Th0mas L.J0hnson; B. Woodrow Wyatt [57] ABSTRACT Aryl substituted diketones and keto-esters, useful as antiviral agents and insecticides, are prepared by reacting an arylalkyl or arylalkenyl iodide with a metal salt of the appropriate diketone or keto-ester.

7 Claims, No Drawings CYCLOPROPYL CARBINOL DERIVATIVES This application is a continuationin-part of my copending application Serial No. 265,333, filed June 22, 1972, now US. Pat. 3,829,475.

This invention relates to aryl substituted diketones and keto-esters, to the preparation thereof and to certain novel intermediates.

The compounds of the invention are of the structural formula wherein Y is selectedfrom thegroup consisting of:

R is lower-alkanoyl of 2 to 6 carbon atoms;

R" is lower-alkanoyl of 2 to 6 carbon atoms or carbolower-alkoxy of 2 to 6 carbon atoms;

R is hydrogen, lower-alkyl of l to 4 carbon atoms or chloro; I

R is hydrogen or lower-alkyl of l to 4 carbon atoms;

Z is a single bond, vinylene (only when the remainder of Y is unsaturated) or ethylene (only when Y is saturated);

Z is a single bond, methylene or ethylene; and

Ar is phenyl, naphthyl or phenyl substituted by 3,4- methylenedioxy or from one to three monovalent substituents selected from the group consisting of loweralkyl of 1 to 4 carbon atoms, lower-alkoxy of 1 to 4 car- 15 bon atoms, carbo-lower-alkoxy of 2 to 4 carbon atoms,

' halogen, trifluoromethyl, trifluoromethoxy, hydroxy, acyloxy of 1 to 10 carbon atoms, benzyloxy, alkanoylamino 'of l to 4 carbon atoms, dialkylamino where alkyl has from 1 to 4 carbon atoms, and aminosulfonyl. I The carbon chains of R, R, R", R and Ar substituents can be straight or branched, although primary or secondary alkylmoieties are preferred.

When two or three monovalent substituents are presem; on the phenyl ring of Ar, they can be the same or different. V

The compounds of the invention where Z and Z are both single bonds and R is hydrogen are prepared as described in the following Reaction Sequences A and Reaction Sequence A R CH: R CH Ar i c +0HC-Ar c C I n Ill 1 LiAll-l,

R nPBr,

. 7 u v H, c|-|,\ Ar R CH Ar -Br CH, ,c -r cu, ulnar, CH cu,

OH W l- CH, c CH, Ar v cH-w 1 cu, CH CH,

v R"\, cH c cu, Ar

CH/ .,CH CH CH/ -continued Reaction Sequence A 1 R" CH; /CH CH, Ar 4 CH CH CH CH' In the foregoing Reaction Sequence A, a l-R-I- acetylcyclopropane of formula II, Where R has the meaning given hereinabove, is treated with an aldehyde ArCI-IO in the presence of a base to give the arylvinyl l-R-cyclopropyl ketone of formula III. The latter, when treated with an alkali metal aluminum hydride, preferably lithium aluminum hydride, is reduced at both the carbonyl group and the olefinic linkage to give an arylethyl l-R-cyclopropyl carbinol of formula IV. This carbinol is then treated with phosphorus tribromide in the presence of a metal bromide such as lithium bromide to replace the hydroxy group by bromine, which product is then treated with zinc bromide to effect ring opening to form an arylalkenyl bromide of formula V. The latter with a metallic iodide is converted to the corresponding iodide of formula VI. The iodide then is treated with the alkali metal enolate salt of a diketone or keto-ester of formula (R)(R)CI-I M where R and R" have the meanings given hereinabove and M is an alkali metal, preferably lithium. The reaction takes place in an inert solvent under anhydrous conditions and produces a compound of formula I where R is hydrogen and Y is -C(R)==CI-ICI-I CI-I Catalytic hydrogenation of the latter, for example with palladium,

platinum or rhodium catalyst, reduces the olefinic linking to afford a compound of formula I where R is hydrogen and Y is CH(R)CH CI-I CH Alternatively, hydrogenation of the double bond may be performed earlier in the synthesis, upon the unsaturated bromide of formula V. Hydrogenation of the latter in the presence of palladium or platinum oxide catalyst produces a saturated bromide of formula The latter in turn is converted to the corresponding io- It has also been found that saturated bromides of formula Va can be caused to react directly with the metallo derivative (R')(R")CH M without interme- 45 diate conversion to the iodides Vla, to form final products. of formula I. The iodide reaction takes place at temperatures of 2060C., whereas the bromide reaction requires a higher temperature, about 100l50C.

In Reaction Sequence B the arylvinyl l-R-cyclopropyl ketone of formula III is treated with an alkali metal borohydride, preferably sodium borohydride to reduce the carbonyl group but not the olefinic linkage and provide an arylvinyl l-R-cyclopropyl carbinol of formula VII. By procedures analogous to those shown in Reac tion Sequence A, the carbinol of formula VII is treated with phosphorus tribromide in the presence of a metal bromide and then with zinc bromide to give a diunsaturated aralkyl bromide of formula VIII. The latter is then converted to the corresponding iodide (IX), which reacts with the alkali metal enolate salt of a diketone or keto-ester to afford a compound of formula I where R is hydrogen and Y is C(R)=CHCI-I=CH-. If desired, the latter can be catalytically hydrogenated to produce a compound of formula I where Y is CI-I(R)CI-I CI-I CI-I In the event that compounds of formula I where the variable Z defined above is vinylene (CI-I=CI-I) are desired, the same reaction sequence as in A can be carried out starting with cinnamaldehyde or a substituted cinnamaldehyde of the formula OHCCI-I=CI-IAr.

Also, the first step of Reaction Sequence A can be used to produce the corresponding aryl-CI-I=CH-vinyl l-R-cyclopropyl ketone for similar use as the srating material in Reaction Sequence B. Catalytic hydrogenation of the compounds where Z is vinylene affords the compounds where Z is ethylene.

'If it is desired to obtain compounds of formula I wherein Ar is substituted by from one to three hydroxy groups, it is necessary to carry out the reaction sequences with the corresponding compounds where Ar is substituted by from one to three benzyloxy groups. The benzyloxy group or groups can then be cleaved by catalytic hydrogenolysis. Any unsaturated linkages in the aliphatic bridge are also hydrogenated at the same time. Alternatively, if it is desired to obtain compounds where Ar is substituted by one or more free hydroxy groups and where the aliphatic bridge is unsaturated, the hydroxy group(s) can be protected throughout the syntheses by esterification (as acetate or benzoate), and the ester hydrolyzed as the final step.

The compounds of formula I where the aryl group is substituted by acyloxy can also be prepared by conventional esterification of the corresponding-hydroxy compounds of formula I with the appropriate acid, acid halide or acid anhydride. The acyloxy groups are derived from carboxylic acids having from one to about ten carbon atoms, and having a molecular weight less than about 200. Representative of the. acyl radicals which can be present are lower-alkanoyl radicals, e.g., formyl,

acetyl, propionyl, butyryl, isobutyryl, caproyl, heptankenoyl radicals, such as phenylacetyl, B-phenylpropionyl, cinnamoyl, and the like; monocarbocyclic aryloxylower-alkanoyl radicals, such as p-chlorophenoxyacetyl, and the like; and amino-lower-alkanoyl, such as glycinyl, alaninyl, morpholinyl, butyryl, and the like. When monocarbocyclic aryl groups are present in the ester moieties, monocarbocyclicaryl includes phenyl and phenyl substituted by from one to three loweralkyl, lower-alkoxy, halogen or, nitro groups.

In the reaction of the arylalkyl iodides or arylalkenyl iodides of formulas VI or IX with the metal enolate salt of a diketone or keto-ester, some of the iodide reactant undergoes dehydrohalogenation to produce a com pound of the formula non-polar character than ,the latter. Selected compounds of formula X having the structure cli qt-cecncu cawhen .R is lower-alkyl of 1-4 carbon atoms have been isolated and characterized and are within the purview of the invention. The dehydrohalogenation reaction occurs in the presence of any basic reagent.

The compounds of formula I when R is chloro can be prepared by treating the corresponding compounds of formula I when R is hydrogen with a chlorinating agentJAn appropriate chlorinating agent is one which introduces a chlorine atom in a position alpha to a carbonyl group. Examples of appropriate chlorinating agents are t-butyl hypochlorite, cupric chloride and sulfuryl chloride. 7

The" compounds of formula I where R is lower-alkyl can be prepared by treating the corresponding compounds of formula I where R is hydrogen with a loweralkyl iodide in the presence of a strong base under anhydrous conditionsQThe strongbasecan be an alkali metal alkoxide, hydride or amide, or'a strong organic amine such as l,5-diazabicyclo[5.4.0]undec-5-ene.

The compounds of formula I abovewhere Z is CH, or CI-I CI-I are prepared by homologation reactions carried out on the intermediate iodides (formulas VI, VIa, IX). For one-carbon homologation (Z is CH the iodide is interacted with thioanisole and phenyllithium to'produce a phenyl thioether where the iodine atom is replaced by C I-I SCI-I,. The'phenyl thioether is then heated with methyl iodide which replaces the 7 C,H S group by iodine, yielding the next higher homolog of the original iodide.

For two-carbon homologation (Z' is CH CH the intermediate iodide of formula VI, VIa or IX is condensed with an alkali metal salt of a malonic ester to give a compound of the formula Alkyl-O Alkyl-0 The compound of formula XI is then hydrolyzed and decarboxylated with aqueous alkali to producea monobasic acid (XII):

Lithium-aluminum hydride reduction of the latter acid converts it to the alcohol (XIII):

HOCH,CH CH CH,Y-Ar

The latter alcohol is converted to the corresponding iodide by treating its p-toluenesulfonate ester withsodium iodide. The iodide, when condensed with the alkali metal salt of a'diketone or keto ester, (R')(R")- CHM", affords compounds of formula I where Z is Cl-l CH Biological evaluation of the compounds of formula I has shown that they possess antiviral activity. They have been found to be effective in vitro against a variety of viruses, including rhino-2, equine rhino, human rhino, para-influenza, herpes and respiratory syncitial virus at minimal growth inhibitory concentrations (mic) ranging from about 0.3 to about 50 micrograms per milliliter. The mic values were determined by standard serial dilution procedures. Certain of the intermediates of formulas III, IV and VIII also showed antiviral activity.

The compounds of formula I and Xa have also been found to possess pesticidal activity. They showed juvenile hormone-like activity when tested under simulated field conditions in a greenhouse against one or more of the following pest species: yellow mealworm pupae, dock beetle larvae, cabbage looper larvae, yellow fever mosquito larvae and rhodnius prolixus nymph.

The structures of the compounds of the invention were established by the modes of synthesis, by elementary analysis, and by infrared and nuclear magnetic resonance spectral determinations.

A further aspect of the invention relates to compositions for combatting arthropods by hindering the maturation thereof which comprise an effective amount of at least one compound of formula I in admixture with a suitable carrier or diluent, and to the method of combatting arthropods at any stage of their development by contacting them with said compositions.

The compositions of the invention are effective against insects at any stage of their development short of the final adult form, i.e., at the egg, larval or pupal stages. The compounds can be formulated in conventional manner as solutions, emulsions, suspensions,

8 dusts and aerosol sprays. The pesticide compositions of the invention can contain adjuvants found normally in such preparations, including water and/or organic solvents such as acetone, dimethylformamide, sesame oil, petroleum oils, and\the like. Emulsifying and surface active agents may also be added. Dust formulations can contain talc, diatomaceous earth, kaolin, bentonite, calcium carbonate, wood, flour, cork, carbon, and the like. The aerosol sprays contain propellants such as dichlorodifluoromethane. The compounds of this invenv tion can be employed as the sole pesticide component or they can be used in admixture with other compounds having similar utility. While the concentration of active ingredient can vary within rather wide limits, ordinarily the pesticide will comprise not more than about 10%, and preferably about 1% by weight of the composition.

A still further aspect of the invention relates to compositions for combatting viruses which comprise an antivirally effective amount of at least one compound of formula I in admixture with a suitable carrier or diluent, and to the method of combatting viruses by contacting the locus of said viruses with said compositions.

The antiviral compositions are formulated by preparing a dilute solution or suspension in an organic or aqueous-organic medium, for example ethyl alcohol, acetone, dimethylsulfoxide, and the like; and are applied to the locus to be disinfected by conventional means such as spraying, swabbing or immersing. Alternatively, the compounds can be formulated as ointments or creams by incorporating them in conventional ointment or cream bases, such as alkylpolyether alcohols, cetyl alcohol, stearyl alcohol and the like; as jellies by incorporating them in conventional jelly bases such as glycerin and tragacanth; or as aerosol sprays or foams. i

The following examples will further illustrate the invention.

PREPARATION OF INTERMEDIATES .A. 2 -Arylvinyl cyclopropyl ketones (III) Al. 2-(3,4-Methylenedioxyphenyl)vinyl l-ethylcyclopropyl ketone [III; Ar is 3,4-methylen edioxyphenyL-R is C I-l A mixture of 33.6 g. (0.3 mole) of l-ethylcyclopropyl methyl ketone and 45 g. (0.3 mole) of piperonal in 21 ml. of ethanol was stirred at room temperature, and 21 m1. of 20% aqueous sodium hydroxide was added dropwise over a period of 30-45 minutes. The mixture was warmed at 40-60C. for three hours with stirring. The solution was then cooled to 0-l0C., 0.2 ml. of glacial acetic acid added, and the mixture was extracted with ether. The ether extracts were concentrated, and the residue dissolved in 200 ml. of ethanol, which solution when cooled caused separation of a solid product. The latter was recrystallized from ml. of methanol to give 39 g. of 2-(3,4-methylenedioxyphenyl)vinyl l-ethylcyclopropyl ketone, m.p. 62-64C.

A2. 2-(3,4-Methylenedioxyphenyl)vinyl cyclopropyl ketone [1"; Ar is 3,4-'methylenedioxyphenyl, R is H] was prepared from 8.4 g. of cyclopropyl methyl ketone and 15 g. of piperonal according to the procedure described above in Preparation Al, affording 21.5 g., m.p. 8587C. when recrystallized from ethanol.

A3. 2-(3,4-Methylenedioxyphenyl)vinyl l-methylcyclopro'pyl ketone (III: Ar is 3,4-methylenedioxyphenyl, ris CH was prepared from 25.6 g. of l-methylcyclopropyl methyl ketone and 39.3 g. of piperonal accord- 9 ing to the procedure described above in Preparation Al, affording 29.5 g. of crystaline product.

A4. 2-(3,4-Dimethoxyphenyl)vinyl l-ethylcyclopropyl ketone [111; Ar is 3,4-(CH O) C H R is C H was prepared from 22.4 g. of l-ethylcyclopropyl methyl ketone and 33.2 g. of veratraldehyde according to the procedure described above in Preparation Al, affording 20.3 g., b.p. 156158C. (0.02 mm.).

A5. 2-(4-Methoxyphenyl)vinyl cyclopropyl ketone [111 Ar is 4-CH OC H R is H] was prepared from 84.1 g. of cyclopropyl methyl ketone and 136 g. of pmethoxybenzaldehyde according to the procedure described above in Preparation Al affording 173.5 g., m.p. 7072C. when recrystallized from ethanol.

A6. 2-Phenylvinyl cyclopropyl ketone [111; Ar is C H R is H] was prepared from 13.5 g. of cyclopropyl methyl ketone and 17.1 g. of benzaldehyde according to the procedure described above in Preparation Al, affording 23.0 g., m.p. 5860C. when recrystallized from absolute ethanol.

A7. 2-(4-Chlorophenyl)vinyl cyclopropyl ketone [111; Ar is 4-ClC H R is H] was prepared from 25.2 g. of cyclopropyl methyl ketone and 42 g. of p-chlorobenzaldehyde according to the procedure described above in Preparation Al, affording 31 g., m.p. 6365C. when recrystallized from ethanol.

A8. 2-(p-Tolyl)vinyl cyclopropyl ketone [111; Ar is 4-CH C H R is H] was prepared from 84.1 g. of cyclopropyl methyl ketone in 120 g. of p-tolualdehyde according to the procedure described above in Preparation Al, affording 158.7 g., colorless plates, m.p. 7880C. when recrystallized from ethanol.

A9. 2-(4-Carboxyphenyl)vinyl l-ethylcyclopropyl ketone [111; Ar is 4-HO CC H R is C H was prepared from 67.2 g. of l-ethylcyclopropyl methyl ketone and 90 g. of p-carboxybenzaldehyde according to the procedure described above in Preparation Al, affording 40 g., m.p. 183.5l84.5C. when recrystallized from acetonitrile and then repeatedly from isopropyl alcohol.

By following the procedure of Preparation A] above, l-isopropylcyclopropyl methyl ketone or l-butylcyclopropyl methyl ketone can be caused to react with piperonal to give 2-(3,4-methylenedioxyphenyl)vinyl lisopropylcyclopropyl ketone [111; Ar is 3,4- methylenedioxyphenyl, R is (CH CH], or 2-(3,4- methylenedioxyphenyl)vinyl l-butylcyclopropyl 'ketone [111; Ar is 3,4-methylenedioxyphenyl, R is CH CH CH- CH respectively.

By following the procedure of Preparation Al above, cyclopropyl methyl ketone can be caused to react with 3,4-dichlorobenzaldehyde, 2,4-dichlorobenzaldehyde, 4-bromobenzaldehyde, 4-fluorobenzaldehyde, 4- hydroxybenzaldehyde, 4-trifluoromethoxybenzaldehyde or 4-trifluoromethylbenzaldehyde to give, respectively, 2-(3,4-dichlorophenyl)vinyl cyclopropyl ketone [111; Ar is 3,4-Cl C H R is H], 2-(2,4dichlorophenyl)- vinyl cyclopropyl ketone [111; Ar is 2,4-C1 C H R is H], 2-(4-bromophenyl)vinyl cyclopropyl ketone [111; Ar is 4-BrC H R is H], 2-(4-fluor0phenyl)vinyl cyclopropyl ketone [111; Ar is 4-FC H R is H], 2-(4-hydroxyphenyl)vinyl cyclopropyl ketone [111; Ar is 4-HOC H R is H], 2-(4-trifluoromethoxyphenyl)vinyl cyclopropyl ketone [111; Ar is 4-F COC H R is H], or 2-(4-trifluoromethylphenyl)vinyl cyclopropyl ketone [111; Ar is 4-F CC 1-1 R is H]. 2-(4'-Hydroxyphenyl)vinyl cyclopropyl ketone can be esterified with benzoyl chloride 10 to give2-(4-benzoyl0xyphenyl)vinyl cyclopropyl ketone [111; Ar is 4-C H COOC H R is H].

According to the procedures of Preparations Al-A9 using the appropriate starting materials, the following compounds were prepared:

A10. 2-(2,4-Dichlorophenyl)vinyl cyclopropyl ketone [111; Ar is 2,4-Cl C H R is H], yellow solid, m.p. -87C. (from isopropyl alcohol).

Al 1. 2-(4-Acetamidophenyl)vinyl cyclopropyl ketone [111; Ar is 4-CH CONHC H R is H], yellow crystals, m.p. 191-192C.

A12. l-Cyclopropyl-5-(p-methoxyphenyl)-2,4-pentadien-l-one, C H COCH=CHCH43H-C H OCl-l -4, yellow solid, m.p. 13l132.5C. (from ethanol) prepared from 4-methoxycinnamaldehyde and cyclopropyl methyl ketone.

A13. 2-(4-Dimethylaminophenyl)vinyl cyclopropyl ketone [111; Ar is 4-(CH NC H R is H], yellow solid, m.p. 137139C (from ethanol), active against equine rhino virus in vitro at 12 micrograms per milliliter.

A14. 2-(4-Benzyloxyphenyl)vinyl cyclopropyl ketone [111; Ar is 4-C H CH OC H.,, R is H], cream-colored solid, m.p 1l1113C. (from ethanol), active against equine rhino virus in vitro at 12 micrograms per milliliter.

A15. 2-(3,4-Dibenzyloxyphenyl)vinyl cyclopropyl ketone [111; Ar "is 3,4-(C H CH O) C H R is H], cream-colored solid, m.p. -l02C. (from methanol), active against equine rhino virus in vitro at 1.5 micrograms per milliliter.

A16. 2-(4-Trifluoromethoxyphenyl)vinyl cyclopropyl ketone [111; Ar is 4-F COC H R is H].

A17. 2-(l-Naphthyl)vinyl cyclopropyl ketone [111; Ar is l-naphthyl, R is H].

A18. 2-(4-Fluorophenyl)vinyl cyclopropyl ketone [111; Ar is 4-PC H R is H].

A19. 2-(4-Diethylaminophenyl)vinyl cyclopropyl ketone [111; Ar is 4-(C H NC H R is H], yellow solid, m.p. 798lC. (from ethanol).

A20. 2-(4-Benzyloxy-3,5-dimethoxyphenyl)vinyl cyclopropyl ketone [111; Ar is 3,5(CH O) -4- C H C-1-1 OC H R is H], light yellow crystals, m.p. 98-99C. (from ethanol).

B. 2-Arylethyl cyclopropyl carbinols (1V) and 2-arylvinyl cyclopropyl carbinols (V11) B1. 2-(3,4-Methylenedioxyphenyl)ethyl l-ethylcyclopropyl carbinol [1V; Ar is 3,4-methylenedioxyphenyl, R is C H A suspension of 15 g. of lithium aluminum hydride in about 500 ml. of tetrahydrofuran was heated at reflux while a solution of 60 g. of 2-(3,4-methylenedioxyphenyl)vinyl l-ethylcyclopropyl ketone (Preparation Al) in ml. of tetrahydrofuran was added dropwise over a period of 2-3 hours. The reaction mixture was heated at reflux for two hours, cooled, and then water was added very cautiously. Excess anhydrous sodium sulfate was added, the mixture filtered, and the filter cake washed several times with chloroform. The combined filtrate and washings were evaporated to dryness to give 53 g. of an oil consisting of 2-(3,4-methylenedioxyphenyl)ethyl l-ethylcyclopropyl carbinol.

B2. 2-(3,4-Methylenedioxyphenyl)ethyl cyclopropyl carbinol [1V; Ar is 3,4-methylenedioxyphenyl, R is H] was prepared from 18.4 g. of 2-(3,4-methylenedioxyphenyl)vinyl cyclopropyl ketone (Preparation A2) and 3.1 g. of lithium aluminum hydride according to the procedure described above in Preparation B1, afford- 1 1 ing 11.5 g., b.p. ll6122C. (0.005 mm.), 6465C. when recrystallized from ether.

B3. 2-(3,4-Methylenedioxyphenyl)ethyl l-methylcyclopropyl carbinol [IV; Ar is 3,4-methylenedioxyphenyl, R is CH;,] was prepared from 23.4 g. of 2-(3,4- methylenedioxyphenyl)vinyl l-methylcyclopropyl ketone (Preparation A3) and 3.88 g. oflithium aluminum hydride according to the procedure described above in Preparation B1, affording 18.8 g., b.p. 120-130C. (0.003 mm).

B4. 2-(3,4-Dimethoxyphenyl)ethyl l-ethylcyclopropyl carbinol [1V; Ar is 3,4-(CH O) C H R is C H was prepared from g. of 2-(3,4-dimethoxyphenyl)vinyl l-ethylcyclopropyl ketone (Preparation A4) and 2.2 g. of lithium aluminum hydride according to the procedure described above in Preparation B1, affording 10 g., b.p. 148150C. (0.01 mm.).

B5. 2-(4-Methoxyphenyl)ethyl cyclopropyl carbinol [lV; Ar is 4-CH OC H R is H] was prepared from 50 g. of 2-(4-methoxyphenyl)-vinyl cyclopropyl ketone (Preparation A5) and 9.7 g. of lithium aluminum hydride according to the procedure described above in Preparation B1, affording 42 g., b.p. 116117C. (0.05 mm.).

B6. 2-Phenylethyl cyclopropyl carbinol [lV; Ar is C H R is H] was prepared from 23 g. of 2-phenylvinyl cyclopropyl ketone (Preparation A6) and 5.22 g. of lithium aluminum hydride according to the procedure described above in Preparation Bl, affording 18.5 g., b.p. 8990C. (0.02 mm.).

B7. 2-(4-Chlorophenyl)ethyl cyclopropyl carbinol [1V; Ar is 4-ClC H R is H] was prepared from 31 g. of 2-(4-chlorophenyl)-vinyl cyclopropyl ketone (Preparation A7) and 5.87 g. of lithium aluminum hydride according to the procedure described above in Preparation B1, affording 23.8 g., b.p. 105106C. (0.1 mm.).

B8. 2-(p-Tolyl)ethyl cyclopropyl carbinol [IV; Ar is 4-CH C H R is H] was prepared from 158 g. of 2-(ptolyl)vinyl cyclopropyl ketone (Preparation A8) and 33.2 g. of lithium aluminum hydride according to the procedure described above in Preparation Bl, affording 137 g., b.p. 9798C. (0.13 mm.).

B9. 2-(4-Carboxypheny1)vinyl 1ethylcyclopropyl carbinol [VII; Ar is 4-HO CC H R is C H To a stirred suspension of 34.0 g. of 2-(4-carboxyphenyl)vinyl l-ethylcyclopropyl ketone (Preparation A9) in 500 ml. of ice water was slowly added 11 g. of sodium borohydride over a one hour period. The mixture was stirred for about sixteen hours and then cautiously acidified with ice-cold concentrated hydrochloric acid. The solid material was collected by filtration and dissolved in ether. The ether solution was dried over anhydrous magnesium sulfate and concentrated to give 33.2 g. of 2-(4-carboxyphenyl)vinyl l-ethylcyclopropyl carbinol, m.p. l30-131C. when recrystallized from toluene.

B10. 2-(4-Carboxyphenyl)ethyl l-ethylcyclopropyl carbinol [IV; Ar is 4-HO CC H R is C H A solution of 29 g. of 2-(4-carboxyphenyl)vinyl 1- ethylcyclopropyl carbinol (Preparation B9) in 200 ml. of ethanol was hydrogenated in the presence of 1 g. of palladium-on-carbon catalyst. There was thus obtained 28 g. of 2-(4-carboxyphenyl)ethyl l-ethylcyclopropyl carbinol, colorless crystals, m.p. 1 16-117.5C.

B1 1. 2-(3,4-Methylenedioxyphenyl)vinyl l-ethylcyclopropyl carbinol [V1I; Ar is 3,4-methylenedioxyphenyl, R is C H To a cold solution of 5 g. of 2-(3,4-methylenedioxyphenyl)vinyl l-ethylcyclopropyl ketone (Preparation A l) in 50 ml. of methanol was added in portions 1.56 g. of sodium borohydride. The mixture was stirred at room temperature for two hours, then diluted with water and extracted with ether. The ether extracts were dried and concentrated to give 3.6 g. of 2-(3,4- methylenedioxyphenyl)vinyl l-ethylcyclopropyl carbinol as a colorless oil.

By replacing the 2-(3,4-methylenedioxyphenyl)vinyl l-ethylcyclopropyl ketone in Preparation B1 above by CH CH CH CH 2-(3,4-dichlorophenyl)ethyl cyclopropyl carbinol [1V; Ar is 3,4-Cl C H R is H], 2-(2,4- dichlorophenyl)ethyl cyclopropyl carbinol [IV; Ar is 2,4-Cl C H R is H], 2-(4-bromophenyl)ethyl cyclopropyl carbinol [1V; Ar is 4-BrC H R is H], 2-(4- fluorophenyl)ethyl cyclopropyl carbinol [1V; Ar is 4- FC H R is H], 2-(4-benzoyloxyphenyl)ethyl cyclopropyl carbinol [1V; Ar is 4-C H COOC H R is H], 2-(4- trifluoromethoxyphenyl)-ethyl cyclopropyl carbinol [IV; Ar is 4-F COC H R is H], or 2-(4-trifluoromethylphenyl)ethyl cyclopropyl carbinol [1V; Ar is 4- F CC H R is H].

According to the procedure of Preparations Bl-Bll using the appropriate starting materials, the following compounds were prepared:

B12. 2-(2,4-Dichlorophenyl)ethyl cyclopropyl carbinol [IV; Ar is 2,4-Cl C H R is H], b.p. 119-126C. (0.2 mm.), prepared from compound of Preparation A10.

B13. 2-(4'Acetamidophenyl )ethyl cyclopropyl carbinol [IV; Ar is 4-CH CONHC H R is H], m.p. l42143C., prepared from compound of Preparation A1 1.

B14. 4-(4-Methoxyphenyl)-3-butenyl cyclopropyl carbinol, C H CH(OH)CH CH CH=CHC H OCH -4, b.p. l31132C. (0.1 mm.), prepared from compound of Preparation A12.

B15. 2-(4-Dimethylaminophenyl)vinyl cyclopropyl carbinol [V1I; Ar is 4-(CH NC H.,, R is H], creamcolored solid, m.p. 7678C. (from ethanol-pentane), prepared from compound of Preparation A13.

B16. 2-(4-Dimethylaminophenyl)ethyl cyclopropyl carbinol [IV; Ar is 4-(CH NC H,,, R is H], pale yellow oil, b.p. l26l28C. (0.2 mm.), prepared from compound of Preparation A13, active against equine rhino virus in virto at 12 micrograms per milliliter.

B17. 2-(4-Benzyloxyphenyl)ethyl cyclopropyl carbinol [IV; Ar is 4-C H CH OC H R is H], m.p. 7677C. (from ether-pentane), prepared from compound of Preparation A14.

B18. 2-(3,4-Dibenzyloxyphenyl)ethyl cyclopropyl carbinol [1V; Ar is 3,4-(C H CH O) C H R is H],

13 mp. 62-64C. (from ether-pentane), prepared from compound of Preparation A15, active against equine rhino virus in vitro at 6 micrograms per milliliter.

B19. 2-(4-Trifluoromethoxyphenyl)ethyl cyclopropyl carbinol 11V; Ar is 4-F COC H R is H], prepared from compound of Preparation A16.

B20. 2-(1-Naphtyl)ethyl cyclopropyl carbinol [[V; Ar is l-naphthyl, R is H], b.p. 145-l46C. (0.01 mm.), prepared from compound of Preparation A17.

B21. 2-(4-Fluorophenyl)ethyl cyclopropyl carbinol [[V; Ar is 4-FC l-1 R is l-l],b.p. 9093C. (0.2 mm.), prepared from compound of Preparation A18.

B22. 2-(4-Diethylaminophenyl)ethyl cyclopropyl carbinol [lV; Ar is 4-(C H NC H R is H], pale yellow oil, b.p. 12913lC. (0.15 mm.), prepared from compound of Preparation A19.

B23. 2-(4-Benzyloxy-3,5-dimethoxyphenyl)ethyl cyclopropyl carbinol [1V; Ar is 3,5-(Cl-l O) -4- C H CH OC l-l R is H], prepared from compound of Preparation A20.

C. Arylalkenyl bromides (V, VIII) and arylalkyl bromides (Va) C l 3-Ethyl-6-( 3,4-methylenedioxyphenyl)-3-hexe nyl bromide [V; Ar is 3,4 methylenedioxyphenyl, R is C 11 To a solution of 26.4 g. (0.106 mole) of 2-(3,4- methylenedioxyphenyl)ethyl l-ethylcyclopropyl carbinol in '250 ml. of ether, cooled to 30C. under nitrogen, was added 18 ml. of collidine. Lithium bromide (26 g., 0.3 mole) was then added, the mixture cooled to -50C. and 25 g. (0.09 mole) of phosphorus tribromide was added dropwise. The reaction mixture was stirred at -50C. for ten minutes, allowed to warm to 0C. over a three hour period and stirred at 0C. for three hours. Collidine (30 ml.) was added, followed by ml. of water. The reaction mixture was partitioned between waterand ether, the ether layer washed with water and sodium chloride solution, and dried over anhydrous magnesium sulfate. The ether solution was concentrated to give an oily product used directly in the following reaction. I

The latter product was dissolved in about 200 ml. of anhydrous ether and added in a fine stream to a stirred mixture of 27 g. of zinc bromide in 200 ml. of ether held at 30 to 35C. The mixture was stirred, then allowed to warm to 0C. during two hours, held there for thirty minutes, and then allowed to warm to room temperature over a three hour period and stirred for two hours longer. The reaction mixture was partitioned between ether and aqueous sodium chloride. The ether layer was washed three times with 500 ml of water, then with sodium chloride solution, dried over anhydrous magnesium sulfate and concentrated to remove the solvent. The residue was redissolved in ether, washed with dilute aqueous sodium bicarbonate and with sodium chloride solution, and evaporated to give 23 g. of 3-ethyl-6-(3,4-methylenedioxyphenyl)-3-hexenyl bromide as a straw-colored oil.

C2. 6-(3,4-Methylenedioxyphenyl)-3-hexenyl bromide [V; Ar is 3,4-methylenedioxyphenyl, R is H] was prepared from 11.5 g. of 2-(3,4-methylenediox yphenyl)ethyl cyclopropyl carbinol (Preparation B2), 12 g. of phosphorus tribromide, 10 g. of lithium bromide and 12.7 g. of zinc bromide according to the procedure given above in Preparation Cl, affording 12.5 g. of product as an oil.

mide [V; Ar is 3 ,4-(CH O) C H R is C 11 was prepared from 16 g. of 2-(3,4-dimethoxyphenyl)ethyl 1ethylcyclopropyl carbinol (Preparation B4), 16.8 g. of phosphorus tribromide, 16.8 g. of lithium bromide and 17.6 g. of zinc bromide according to the procedure given above in Preparation C1. The product was used directly in the succeeding step (Preparation D4) with-' out isolation.

C5. 6-(4-Methoxyphenyl)-3-hexenyl bromide [V; Ar is 4-CH OC H R is H] was prepared from 38.2 g. of 2-(4-methoxyphenyl)ethyl cyclopropyl carbinol (Preparation B5 42.5 g. of phosphorus tribromide, 35 g. of lithium bromide and 40 g. of zinc bromide according to the procedure given above in Preparation Cl affording 48 g. of product as an oil.

C6. 6-Phenyl-3-hexenyl bromide [V; Ar is' C 11 R is H] was prepared from 16.5 g. of 2-phenylethyl cyclopropyl carbinol (Preparation B6), 21.5 g. of phosphorus tribromide, 17.65 g. of lithium bromide and 20.7 g. of zinc bromide according to the procedure given above in Preparation Cl, affording 21 g. of product as a pale yellow oil.

C7. 6-(4-Chlorophenyl)-3-hexenyl bromide [V; Ar is 4-ClC l-l R is H] was prepared from 21 g. of 2-(4- chlorophenyl)ethyl cyclopropyl carbinol (Preparation B7), 23 g. of phosphorus tribromide, 18.85 g. of lithium bromide and 22.5 g. of zinc bromide according to the procedure given above in Preparation Cl, affording 25.5 g. of product as an oil.

C8. 6-(p-Tolyl)-3-hexenyl bromide [V; Ar is 4- CH C l-l R is H] was prepared from 2-(p-tolyl)ethyl cyclopropyl carbinol (Preparation B8), phosphorus tribromide, lithium bromide and zinc bromide according to the procedure given above in Preparation C1.

C9. 3-Ethyl-6-(4-carbomethoxyphenyl)-3-hexenyl bromide [V; Ar is 4-CH O CC H R is C l-1 A mixture of 21.3 g. of 2-(4-carboxyphenyl)vinyl 1- ethylcyclopropyl carbinol (Preparation B9) and 500 ml. of methanol saturated with hydrogen chloride at 0C. was stirred for one hour at 0C. and then allowed to come to room temperature with stirring until the so lution was complete. The reaction mixture was concentrated to dryness, the residue taken up in chloroform and washed with water and sodium bicarbonate solution, dried over anhydrous magnesium sulfate and concentrated to give 24.4 g. of a light yellow oil. The latter product was dissolved in a small quantity of ether and added to a solution of 700 g. of zinc bromide in 4 liters of anhydrous ether. The reaction mixture was stirred for twenty hours, then washed with water, dried over anhydrous magnesium sulfate and the solvent evaporated, affording 17.5 g. of 3-ethyl-6-(4-carbomethoxyphenyl)-3-hexenyl bromide as a light yellow oil.

C10. 3-Ethyl-6-(3,4-methylenedioxyphenyl)-3,5- hexadienyl bromide [VII]; Ar is 3,4-methylenedioxyphenyl, R is C H was prepared from 3.6 g. of 2-(3,4- methylenedioxyphenyl)vinyl l-ethylcyclopropyl carbinol (Preparation B1 1), 3.5 g. of phosphorus tribromide, 4.5 g. of lithium bromide and 3.5 g. of zinc bro- 15 mide according to the procedure given above in Preparation Cl, affording 2 g. of product as an oil.

C1 1. 6-(4-Methoxyphenyl)hexyl bromide [Va; Ar is 4-CH OC H,, R is H].

A mixture of 18.6 g. of 6-(4-methoxyphenyl)-3-hexenyl bromide (Preparation C5) and 0.21 g. of platinum oxide catalyst in 200 ml. of isopropyl alcohol was bydrogenated until 1 mole equivalent of hydrogen had been absorbed. The product was isolated and distilled to give 12.8 g. of 6-(4-methoxypheny1)-hexyl bromide, b.p. 126-128C. (0.04 mm.).

C12. 6-Phenylhexyl bromide [Va; Ar is C H R is H was prepared by hydrogenation of 21 g. of 6-phenyl-3- hexenyl bromide (Preparation C6) according to the procedure described above in Preparation C1 1, affording 16 g., b.p. 8687C. (0.02 mm.).

C13. 6-(4-ch1orophenyl)hexyl bromide [Va; Ar is 4- ClC H R is H] was prepared by hydrogenation of 25.2 g. of 6-(4-ch1oropheny1)-3-hexeny1 bromide (Preparation C7) according to the procedure described above in Preparation C11, affording 17 g., b.p. 110l 11C. (0.02 mm.).

C14. 6-(p-To1y1)hexyl bromide [Va; Ar is 4- CH C H R is H] was prepared by hydrogenation of 6-(p-to1y1)-3-hexeny1 bromide according to the procedure described above in Preparation C11. I

By replacing the 2-(3,4-methylenedioxypheny1)ethyl l-ethylcyclopropyl carbinol in Preparation C1 by a molar equivalent amount of 2-(3,4-methylenedioxyphenyl)ethyl l-isopropylcyclopropyl carbinol, 2-(3,4- methylenedioxyphenyl)-ethy1 l-butylcyclopropyl carbinol, 2-(3,4-dich1oropheny1)ethyl cyclopropyl carbinol, 2-(2,4-dich1orophenyl)ethyl cyclopropyl carbinol, 2-(4-bromopheny1)ethy1 cyclopropyl carbinol, 2-(4- fluoropheny1)ethy1 cyclopropyl carbinol, 2-(4-benzoy1oxypheny1)-ethy1 cyclopropyl carbinol, 2-(4-trifluoromethoxypheny1)ethy1 cyclopropyl carbinol or 2- (4-trifluoromethylpheny1)ethyl cyclopropyl carbinol there can be obtained, respectively, 3-isopropy1-6-(3,4- methylenedioxyphenyl)-3-hexeny1 bromide [V; Ar is 3,4-methy1enedioxypheny1, R is (CH CH], 3-buty1-6- (3,4-methylenedioxypheny1)-3-hexenyl bromide [V; Ar is 3,4-methylenedioxypheny1, R is CH CH CH,CH 6-(3,4-dichloropheny1)-3-hexenyl bromide [V; Ar is 3,4-CI C H R is H], 6-(2,4- dichlorophenyl)-3-hexenyl bromide [V; Ar is 2,4- Cl C H R is H], 6-(4-bromopheny1)-3-hexenyl bromide [V; Ar is 4-BrC H,, R is H], 6-(4-fluorophenyl)- 3-hexenyl bromide [V; Ar is 4-FC H R is H], 6-(4- benzoyloxyphenyl)-3-hexenyl bromide [V; Ar is 4- C'H5COOC6H4, R is H], 6-(4-trifluoromethoxypheny1)-3-hexenyl bromide [V; Ar is 4-F COC H R is H], or 6-(4-trifluoromethylphenyl)-3-hexeny1 bromide [V; Ar is 4-F CC H R is H].

The latter products can be hydrogenated according to the procedure of Preparation C11 to give, respectively, 3-isopropy1-6-( 3,4-methy1enedioxyphenyl)hexyl bromide [Va; Ar is 3,4-methy1enendioxypheny1, R is (CH CH], 3-buty1-6-(3,4-methylenedioxypheny1)- hexyl bromide [Va; Ar is 3,4-methylenedioxyphenyl, R is CH CH,CH,CH 6-(3,4-dichlorophenyl)hexy1 bromide [Va; Ar is 3,4-C1 C H R is H], 6-(2,4-dich1oropheny1)hexyl bromide [Va; Ar is 2,4-C1 C H R is H], 6-(4-bromophenyl)hexy1 bromide [Va; Ar is 4-BrC H.,, R is H], 6-(4-fluoropheny1)hexyl bromide [Va; Ar is 4-FC H R is H], 6-(4-trifluoromethoxypheny1)hexyl bromide [Va; Ar is 4-F COC H R is H], or 6-(4-triflfuoromethylphenyl)hexyl bromide [Va; Ar is 4- F CC H R is H].

According to the procedures of Preparations C1-C14 using the appropriate starting materials, the following compounds were prepared:

C15. 6-(2,4-Dichlorophenyl)-3-hexeny1 bromide [V; Ar is 2,4-Cl C H R is H], prepared from compound of Preparation B12.

C16. 6-(2,4-dich1oropheny1)hexyl bromide [Va; Ar

is 2,4-C1 C H R is H], prepared by hydrogenation of the compound of Preparation C15.

C17. 6-(4-Acetamidophenyl)-3-hexeny1 bromide [V; Ar is 4-CH CONHC H R is H], prepared from the compound of Preparation B13.

C18. 8-(4-Methoxyphenyl)-3,7-octadieny1 bromide, BrCH CH CH=CHCH CH CH=CHC H OCH -4, prepared from the compound of Preparation B14.

C19. 6-(4-Dimethylaminopheny1)-3-hexeny1 bromide [V; Ar is 4-(CH NC H R is H], prepared from the compound of Preparation B15.

C20. 6-(4-Benzy1oxypheny1)-3-hexenyl bromide [V; Ar is 4-C H CH,OC H R is H], prepared from the compound of Preparation B17.

C21. 6-(3,4-Dibenzyloxyphenyl)-3-hexenyl bromide [V; Ar is 3,4-(C H CH,O) C H R is H], prepared from the compound of Preparation B18.

C22. 6-(4-Trifluoromethoxypheny1)-3-hexeny1 bromide [V; Ar is 4-F -,COC,,H.,, R is H], prepared from the compound of Preparation B19.

C23. 6-( lNaphthy1)-3-hexeny1 bromide [V; Ar is 1- naphthyl, R is H], prepared from the compound of Preparation B20.

C24. 6-(1-Naphthy1)hexyl bromide [Va; Ar is 1- naphthyl, R is H], b.p. -146C. (0.01 mm.), prepared by hydrogenation of the compound of Preparation C23.

C25. 6-(4-F1uorophenyl)-3-hexenyl bromide [V; Ar is 4-FC H R is H], prepared from the compound of Preparation B21.

C26. 6-(4-Fluoropheny1)hexy1 bromide [Va; Ar is 4-FC H R is H], by hydrogenation of the compound of Preparation C25.

C27. 6-(4-Diethylaminophenyl)-3-hexenyl bromide [V; A! is 4,-(C H ),NC H R is H], prepared from compound of Preparation B22.

C28. 6-(4-Benzyloxy-3,5-dimethoxyphenyl)-3-hexebromide is 3,5-(CH30)2-4'C6H5CH2OC6H2 R'is H], prepared from compound of Preparation B23.

(V1, 1X) an arylalkyl iodides (Via) D1. 3-Ethyl-6-(3,4-methy1enedioxypheny1)-3-hexenyl iodide [V1; Ar is 3,4-methylenedioxyphenyl, R is 2 5].

A mixture of 23 g. of 3ethy1-6-(3,4-methy1enedioxypheny1)-3-hexenyl bromide (Preparation C1) and 30 g. of powdered potassium iodide in 250 m1. of dimethylformamide was stirred for about sixteen hours. The reaction mixture was concentrated to remove-the solvent and the residue partitioned between cyclohexane and water. The cyclohexane layer was separated; dried over anhydrous magnesium sulfate and evaporated to give 33.0 g. of 3-ethy1-6-(3,4-methylenedioxypheny1)-3- hexenyl iodide as a light 'yellow oil.

D2. 6-(3,4-Methy1enedioxyphenyl)-3-hexeny1 iodide [V]; Ar is 3,4-methylenedioxyphenyl, R is H] was prepared from 12.9 g. of 6-(3,4-methylenedioxyphenyl)-3- hexenyl bromide (Preparation C2) and 7 g. of sodium D. Arylalkenyl iodides 17 iodide in 120 ml. of acetone, refluxed for three hours, affording 12.5 g. of product as an oil.

D3. 3-Methyl-6-(3,4-methylenedioxyphenyl)-3- hexenyl iodide [VI; Ar is 3,4-methylenedioxyphenyl, R is CH was prepared from 19.0 g. of 3-methyl-6-(3,4- methylenedioxyphenyl)-3-hexenyl bromide (Preparation C3) and 10.5 g. of sodium iodide in 125 ml. of acetone, to give 21 g. of product as a yellow oil.

D4. 3-Ethyl-6-(3,4-dimethoxyphenyl)-3-hexenyl iodide [VI; Ar is 3,4-(CH O) C H R is C H was prepared from 13.8 g. of 3-ethyl-6-(3,4-dimethoxyphenyl)-3-hexenyl bromide (Preparation C4) and 9 g. of sodium iodide in 120 ml. of acetone, to give g. of product as an oil.

D5. 6-(4-Methoxyphenyl)-3-hexenyl iodide [VI; Ar is 4-CH OC H R is H] was prepared from 24 g. of 6- (4-methoxyphenyl)-3-hexenyl bromide (Preparation C5) and 14.75 g. of sodium iodide in 475 ml. of 2-butanone, to give 28.5 g. of product as an oil.

D6. 6-(4-Methoxyphenyl)hexyl iodide [VIa; Ar is 4- CH OC H R is H] was prepared from 16.3 g. of 6-(4- methoxyphenyl)hexyl bromide (Preparation C11) and 9.93 g. of sodium iodide in 325 ml. of 2-butanone, to give 19.3 g. of product as a pale yellow oil.

D7. 6-Phenylhexyl iodide [Vla; Ar is C H R is H] was prepared from 16 g. of 6-phenylhexyl bromide (Preparation C12) and 10.95 g. of sodium iodide in 325 ml. of 2-butanone, to give 19.1 g. of product as an oil.

D8. 6-(4-Chlorophenyl)hexy1 iodide [VIa; Ar is 4- ClC H R is H] was prepared from 17 g. of 6-(4- chlorophenyl)hexyl bromide (Preparation C13) and 10.2 g. of sodium iodide in 325 ml. of acetone, to give 21 g. of product as an oil.

D9. 6-(p-Tolyl)hexyl iodide (Via; Ar is 4-CH C H R is H] was prepared from 6-(p-tolyl)hexyl bromide (Preparation C14) and sodium iodide in acetone according to the procedure of Preparation D2 above.

D10. 3-Ethyl-6-(4-carbomethoxyphenyl)-3-hexenyl iodide [VI; Ar is 4-CH O CC H R is C 11 was prepared from 17.5 g. of 3-ethyl-6-(4-carbomethoxypheny1)-3-hexenyl bromide (Preparation C9) and 17.5 g. of sodium iodide in 200 ml. of acetone, to give 14 g. of product as an oil.

D1 1. 3-Ethyl-6-( 3,4-methylenedioxyphenyl)-3,5- hexadienyl iodide [IX; Ar is 3,4-methylenedioxyphenyl, R is C H was prepared from 10 g. of 3-ethyl-6- (3,4-methylenedioxyphenyl)-3,5-hexadienyl bromide (Preparation C10) and 6 g. of sodium iodide in 120 ml. of acetone, to give 10.5 g. of product as an oil.

By similar procedures 3-isopropyl-6-(3,4- methylenedioxyphenyl)hexyl bromide, 3-butyl-6-(3,4- methylenedioxyphenyl)-hexyl bromide, 6-(3,4- dichlorophenyl)hexyl bromide, 6-(2,4-dichlorophenyl)hexyl bromide, 6-(4-bromophenyl)hexyl bromide, 6-(4-fluorophenyl)hexyl bromide, 6-(4-benzoyloxyphenyl)-3-hexenyl bromide, 6-(4-trifluoro methoxyphenyl)hexyl bromide, or 6-(4-trifluoromethylphenyl)hexyl bromide can be caused to react with sodium iodide to give, respectively, 3-isopropyl-6-(3,4- methylenedioxyphenyl)hexyl iodide [Vlag Ar is 3,4- methylenedioxyphenyl, R is (CH CH], 3-butyl-6- (3,4-methylenedioxyphenyl)hexyl iodide [Vla; Ar is 3,4-methylenedioxyphenyl, R is CH CH CH CH 6- (3,4-dichlorophenyl)hexyl iodide [Vla; Ar is 3,4- Cl C H R is H], 6-(2,4-dichlorophenyl)hexyl iodide [VIa; Ar is 2,4-Cl C H R is H], 6-(4-bromophenyl)- hexyl iodide [VIa; Ar is 4-BrC H R is H], 6-(4-fluoro- 18 phenyl)hexyl iodide [Vla; Ar is 4-FC H R is H], 6-(4- benzoyloxyphenyl)-3-hexenyl bromide [VI; Ar is 4- C H COOC H R is H], 6-(4-trifluoromethoxyphenyl)hexyl iodide [Vla; Ar is 4-F COC H R is H], or 6-(4-trif1uoromethylphenyl)-hexyl iodide [Vla; Ar is 4-F CC H R is H].

According to the procedures of Preparations Dl-Dl 1 using the appropriate starting materials, the following compounds were prepared:

D12. 6-(2,4-Dichlorophenyl)hexyl iodide [Vla; Ar is 2,4-Cl -C H R is H], prepared from the compound of Preparation C16.

D13. 6-(4-Acetamidophenyl)-3-hexenyl iodide [VI; Ar is 4-CH CONHC 1-1 R is H], prepared from the compound of Preparation C17.

D14. 8-(4-Methoxyphenyl)-3,7-octadienyl ICH CH CH=CHCH CH CH=CHC H OCH -4, pared from the compound of Preparation C18.

D15. 6-(4-Dimethylaminophenyl)-3-hexenyl iodide [VI; Ar is 4-(CH NC H R is H], prepared from the compound of Preparation C19.

D16. 6-(4-Benzyloxyphenyl)-3-hexenyl iodide [VI; Ar is C H CH OC H R is H], prepared from the compound of Preparation C20.

D17. 6-(3,4-Dibenzyloxyphenyl)-3-hexenyl iodide [VI; Ar is 3,4-(C H CH O) C H R is H], prepared from the compound of Preparation C21.

D18. 6-(4-Trifluoromethoxyphenyl)-3-hexenyl iodide [VI; Ar is 4-F COC H R is H], prepared from the compound of Preparation C22.

D19. 6-( l-Naphthyl)hexyl iodide [Vla; Ar is 1- naphthyl, R is H], prepared from the compound of Preparation C24.

D20. 6-(4-Fluorophenyl)hexyl iodide [Vla; Ar is 4- FC H R is H], prepared from the compound of Preparation C26.

D21. 6-(4-Diethylaminophenyl)-3-hexenyl iodide [VI; Ar is 4-(C H NC H R is H], prepared from the compound of Preparation C27.

D22. 6-(4-Benzyloxy-3,5-dimethoxyphenyl)-3-hexenyl iodide [VI; Ar is 3,5-(CH O) -4-C H CH OC H R is H], prepared from the compound of Preparation C28.

D23. 6-(p-Tolyl)-3-hexenyl iodide [VI; Ar is 4- CH C H R is H], prepared from the compound of Preparation C8.

iodide,

pre-

EXAMPLE 1 4-[3-Ethyl-6-(3,4-methylenedioxyphenyl)-3-hexenyl]- 3,5-heptanedione [1; Ar is 3,4-methylenedioxyphenyl, R is H, R and R" are CH CH CO, Y is A solution of 15 g. of the lithium salt of 3,5-heptanedione (prepared as described in Example 8 below) in m1. of tetramethylurea was stirred under nitrogen at room temperature, and 10 g. of 3-ethyl-6-(3,4- methylenedioxyphenyl)-3-hexenyl iodide (Preparation D1) was added. The reaction mixture was stirred for forty-eight hours, then concentrated to remove the solvent, and the residue slurried in ether and treated with excess glacial acetic acid. Water was added, the ether layer separated, washed with water and concentrated. The residue was distilled in a molecular still to remove volatile material at C. (0.001 mm.), and the nonvolatile residue was chromatographed on 10 g. of activated magnesium silicate in benzene solution and eluted with ethyl acetate to give 4-[3-e thyl-6-(3,4- methylenedioxyphenyl )-3 -hexenyl -3 ,5 -heptanedione enyl]-3,5-heptanedione was found to have pesticidal activity when tested against yellow mealworm pupae (tenebrio) at a concentration of 0.1 microgram per insect, against dock beetle larvae at 1 microgram per insect, against yellow fever mosquito larvae at 15 ppm in water and against rhodnius prolixus nymph at 100 micrograms per insect.

EXAMPLE 2 3-[3-Ethyl-6-(3,4-methylenedioxyphenyl)-3-hexeny1]- 2,4-pentanedione [1; Ar is 3,4-methylenedioxyphenyl, R is H, R and R" are CH CO, Y is C(C,H )=CHCH CH I A mixture of g. of the lithium salt of 2,4-pentanedione (prepared by treatment of 2,4-pentanedione in ether with n-butyllithium by the procedure described in Example 8 below) and 10 g. of 3-ethyl-6-(3,4- methylenedioxyphenyl)-3-hexenyl iodide (Preparation D1) in 100 ml. of tetramethylurea was heated at 60C. for forty-eight hours. The reaction mixture was filtered, the filtrate concentrated in vacuo to a volume of about ml., then diluted with 200 ml. of water and extracted with ether. The ether solution was washed with water and saturated sodium chloride solution, and dried over anhydrous magnesium sulfate. The dried ether solution was concentrated to remove the solvent, and the residue was chromatographed on silica gel. The chromatograph column was eluted with pentane containing 20% benzene which removed unreacted iodide, and then eluted with benzene containing 20% ether, affording 2.4 g. of 3-[3-ethyl-6-(3,4-methylenedioxyphenyl)-3- hexenyl]-2,4-pentanedione as an amber oil.

Anal. Calcd. for C H O C, 72.48; H, 8.21. Found:

IR (oil film) A "'5 3.45mss shldrs. (CH); 5.80 mss, 5.91s (C=O); 6.25m, 6.35m, 6.67mss, 6.73s, 6.96mss (arom CH). Nuclear Magnetic Resonance (NMR) [20% CDCl internal tetramethylsilane (TMS)] 8ppm (Ratio) 663(3) (arom); 5.87(2) (OCH O); 5.08(1) (=CH); 3.53(l) [(O=C) CH]; 1.5-3.0(16) (aliphatic CH COCH X 2); 0.9(3) (Me triplet).

3-[3-Ethyl-6-(3,4-methylenedioxyphenyl)-3-hexenyl]-2,4-pentanedione was found to be pesticidal against yellow mealworm pupae (tenebrio) at a concentration of 100 micrograms per insect, against dock beetle larvae at 20 micrograms per insect, against cabbage looper larvae at 100 micrograms per insect and against rhodnius prolixus nymph at 30 micrograms per insect.

EXAMPLE 3 3-[3-Ethyl-6-(3,4-methylenedioxyphenyl)-3-hexenyl]-2,4-hexanedione [1; Ar is 3,4-methylenedioxyphenyl, R" is H, R is CH CO, R" is CH CH CO, Y is C(C H )=CHCH CH was prepared from 23.2 g. of

20 3-ethyl-6-(3,4-methylenedioxyphenyl)-3-hexenyl iodide (Preparation Dl and 22.3 g. of the lithium salt of 2,4-hexanedione (prepared by the procedure described in Example 8 below) in 300 ml. of dimethylformamide according to the procedure described above in Example 2. There was thus obtained 21 g. of crude product which was chromatographed on 600 g. of silica gel in pentane solution containing 20% benzene. The column was eluted with the pentane-benzene-ether solvent series. Benzene containing 3% ether brought out the desired product, 14.5 g. of 3-[3-ethyl-6-(3,4- methylenedioxyphenyl)-3-hexenyl]-2,4-hexanedione as a yellow oil.

Anal. Calcd. for C ,H O.,: C, 73.23; H, 8.19. Found:

IR (oil film) A a 3.45mss shldrs. (CH); 5.83s, 5.91s (C=O); 6.33m, 6.74s sh1dr., 6.96mss (arom and CH).

NMR (20% CDCl internal TMS) Sppm (Ratio) 6.70(3) (arom); 5.92(2) (O-CH -O); 5.13(1) (=CH); 3.62(l) [(O=C) CH]; 1.7-2.9(15) (aliph. CH, incl. COCH singlet); 1.03(6) (Me triplet X 2).

3 -[3-Ethyl-6-(3,4-methylenedioxyphenyl)-3-hexenyl]-2,4-hexanedione was found to be pesticidal against yellow mealworm pupae (tenebrio) at a concentration of 10 micrograms per insect, against dock beetle larvae at a concentration of 1 microgram per insect and against rhodnius prolixus nymph at 10 micrograms per insect.

In the silica gel chromatographic procedure of Example 3 it is possible to isolate from the early eluates (pentane containing a minor fraction of benzene) a nonpolar substance, which when distilled in vacuo gives 3- ethy1-6-(3,4-methylenedioxyphenyl)-1,3-hexadiene [Xa; R is C 11 b.p. l05C. (0.055 mm.), n 1.5440.

Anal. Calcd. for C H O C, 78.22; 0, 13.89.

Found: C, 78.06; 0, 13.87.

1R (oil film) )t 3.45mss shldrs. (CH); 6.10m, 6.2Smms, 6.67s, 6.74s (arom); 6.95mss (CH).

3-Ethyl-6-[3,4-(methylenedioxy)phenyl]-1,3-hexadiene was found to be pesticidal against dock beetle larvae and rhodnius prolixus nymph.

EXAMPLE 4 Ethyl 2-acetyl-5-ethyl-8-(3,4-methylenedioxyphenyl)-5-octenoate [1; Ar is 3,4-methylenedioxyphenyl, R is H, R is CH CO, R is COOC H Y is C(C H )=CHCH CH was prepared from 9.6 g. of 3- ethyl-6-(3,4-methylenedioxyphenyl)-3-hexenyl iodide (Preparation D1) and 10 g. of the lithium salt of ethyl acetoacetate (prepared by the method described in Example 8 below) in ml. of tetramethylurea according to the procedure described above in Example 2. The reaction was allowed to proceed for five days at 60C., and the resulting product was isolated and chromatographed on silica gel to give 4.9 g. of ethyl 2-acetyl-5-ethyl-8-(3,4-methylenedioxyphenyl)-S-octenaoate as a yellow oil.

Anal. Calcd. for C l-1 0 C, 69.98; H, 7.83. Found:

IR (oil film) A 1" 3.45mss shldrs. (CH), 5.78mss, 5.86s (C=O); 6.15-6.30m, 6.67mss, 6.73s, 6.95mss (arom and CH).

NMR (20% CDCI internal TMS) Sppm (Ratio) 663(3) (arom); 586(2) (O-CH -O);5.l0(1) (=CH); 4.17(2) (OCH quartet); 3.33(l) [(O=C) -CH]; 1.7-2.8(13) (aliph. CH incl. COCH (3), 0.90(3) 2 1 (Me triplet X 2).

Ethyl 2-acetyl-5-ethyl-8-(3,4-methylenedioxyphenyl)--octenoate was found to have a minimum inhibitory concentration in vitro of 6 micrograms per milliliter against equine rhino virus.

EXAMPLE 5 Ethyl 2-propionyl-5-ethyl-8-(3,4-methylenedioxyphenyl)-5-octenoate [1; Ar is 3,4-methylenedioxyphenyl, R is H, R is CH CH CO, R is COOC H Y is C(C H )=CHCH CH was prepared from g. of 3' ethyl-6-(3,4-methylenedioxyphenyl)-3-hexenyl iodide (Preparation D1) and 4.6 g. of the lithium salt of ethyl 3-oxovalerate (prepared by the method described in Example 8 below) in 100 ml. of dimethylformamide by the procedure described above in Example 2. The product was chromatographed on silica gel and eluted with chloroform containing benzene to give 5.5 g. of ethyl 2-propionyl-5-ethyl-8-(3 ,4-methylenedioxyphenyl)-5-octenoate as an amber liquid.

Anal. Calcd. for C H O C, 70.56; H, 8.08.Found:

C, 71.70; H, 8.06. C, 71.60; H, 8.09.

Ethyl 2-propionyl-5-ethyl-8-( 3,4-methylenedioxyphenyl)-5-octenoate was found to have a minimum inhibitory concentration in vitro of 12 micrograms per milliliter against equine rhino virus.

Ethyl 2-propionyl-5-ethyl-8-(3,4-methylenedioxyphenyl)-5-octenoate was found to be pesticidal against yellow mealworm pupae (tenebrio) at a concentration of 10 micrograms per insect.

EXAMPLE 6 Ethyl 2-butyry1-5-ethyl-8-(3,4-methylenedioxyphenyl)-5-octenoate [1; Ar is 3,4-methylenedioxyphenyl, R is H, R is CH CH CH CO, R" is COOC H Y is C(C H )=CHCH CH was prepared from 20 g. of 3-ethyl-6-(3,4-methylenedioxyphenyl)-3-hexenyl iodide (Preparation D1) and 12 g. of the lithium salt of ethyl 3-oxohexanoate (prepared by the method described below in Example 8) according to the procedure described above in Example 2. There was thus obtained 11.57 g. of ethyl 2-butyryl-5-ethyl-8-(3,4- methylenedioxyphenyl)-5-octenoate as a light yellow oil.

Agal. Calcd. for C H O C, 71.11; H,.8.30.F0und:

IR (oil film) 3.45mss shldrs. (CH); 5.78mss, 5.91s (C=O); 6.24m, 6.74mss, 6.68 shldr., 6.96mss (arom and CH). NMR (20% CDCl internal TMS) Sppm (Ratio) 6.73(3) (arom); 5.93(2) (O-CH O); 5.17(1) (=CH); 4.22(2) (OCH CH quartet); 3.42(1 [(O=C) CH], 0.7-2.8(23) (aliph. CH incl. Me triplet X 3).

Ethyl 2-butyryl-5-ethyl-8-(3,4-methy1enedioxyphenyl)-5-octenoate was found to have a minimum inhibitory concentration in vitro of 12 micrograms per milliliter against equine rhino virus.

Ethyl 2-butyryl-5-ethyl-8-(3,4-methylenedioxyphenyl)-5-octenoate was found to be pesticidal against yellow mealworm pupae (tenebrio) at a concentration of 0.3 micrograms per insect and against dock beetle larvae at a concentration of 5 micrograms per insect.

EXAMPLE 7 4-[6-(3,4-Methylenedioxyphenyl)-3-hexenyl]-3,5- heptanedione [1; Ar is 3,4-methylenedioxyphenyl, R is H, R and R are CH CH CO, Y is CH=CHCH CH was prepared from 12.5 g. of 6-(3,4-methylenedioxyphenyl)-3-hexenyl iodide (Preparation D2) and 12.5 g. of the lithium salt of 3,5-heptanedione in 175 ml. of dimethylformamide. The product was chromatographed on silicagel and eluted with pentane-benzene 1:1 and then with chloroform-benzene (7:3). The latter brought out 7.0 g. of 4-[6-(3,4-methylenedioxyphenyl)-3-hexenyl]-3,5-heptanedione as a light amber oil.

Anal. Calcd. for G l-1 0 C, 72.70; H, 7.53.F0und:

IR (oil film) A 3.45mss shldrs. (CH), 5.81mss, 5.91s (C=O); 6.25-6.35m, 6.67mss, 6.74s, 6.95mss (arom and CH). NMR (20% CDCl internal TMS) 8 ppm (Ratio) 6.62(3) (arom); 5.85(2) (OCH,- 0); 535(2) .(=CH X 2), 3.58(1) [(O=C) CH]; 1.7-2.8(12) (aliph. CH); 1.00(6) (Me triplet X 2).

4-[6-(3,4-Methylenedioxyphenyl)-3-hexenyl]-3,5- heptanedione was found to have a minimum inhibitory concentration in vitro of 3-6 micrograms per milliliter against equine rhino virus.

4-[6-(3,4-Methylenedioxyphenyl)-3-hexenyl]-3,5- heptanedione was found to be pesticidal against yellow mealworm pupae (tenebrio) at a concentration of micrograms per insect and against dock beetle larvae at 20 micrograms per insect.

EXAMPLE 8 4-[3-Methyl-6-(3,4-methylenedioxyphenyl)-3-hexenyl]-3,5-heptanedione [1; Ar is 3,4-methylenedioxyphenyl, R is H, R and R are CH CH CO, Y is C(CH )=CHCH CH To 40 g. of 3,5-heptanedione in 400 ml. of ether at 0C. was added dropwise 19.9 g. of n-butyllithium in hexane solution. The mixture was warmed to 25C., filtered and the solid product washed with ether and dried.

The resulting lithium salt of 3,5-heptanedione (20 g.), 20.6 g. of 3-methyl-6-(3,4-methylenedioxyphenyl)- 3-hexenyl iodide (Preparation D3) and 200 ml. of dimethylformamide was stirred at 50C. for 24 hours. Additional dimethylformamide (50 ml.) was then added and the mixture stirred at 60C. for 65 hours. The solution was concentrated in vacuo and the residue triturated with ether several times. The ether solution was washed with water, dried over anhydrous magnesium sulfate and concentrated to give 18 g. of an oil which was chromatographed on 500 g. of silica gel, applied in pentane. The column was eluted with the pentane-benzene-ether solvent sequence. The desired product was brought out by benzene containing 3% ether, affording 10.2 g. of 4-[3-methyl-6-(3,4- methylenedioxyphenyl)-3-hexenyl]-3 ,S-heptanedione as a light yellow viscous oil.

Anal. Calcd. for C ,H O C, 73.23; H, 8.19. Found: C, 73.44; H, 8.34.

[R (oil film) A '5'" 3.45mss shldrs. (CH); 5.83mss, 5.92s (C=O); 6.26m, 6.35m, 6.68mss, 6.74s, 6.96mss shldrs. (arom and CH).

NMR (20% CDCl internal TMS) 8 ppm (Ratio) 663(3) (arom CH); 5.87(2) (O-CH -O); 5.13(1) (=CH); 3.57(1) [(O=C) CH]; 1.4-2.8(15) (aliph. CH); 1.00(3) (Me triplet X 2).

4-[3-Methyl-6-(3,4-methylenedioxyphenyl)-3-hexenyl]-3,5-heptanedione was found to have minimum inhibitory conbentrations in vitro against rhino-2, equine rhino, parainfluenza and resp. syn. virus of 3, 6, 6 and 6 micrograms per milliliter, respectively.

23 4-[3-Methyl-6-(3,4-methylenedioxyphenyl)-3-hexenyl]-3,5-heptanedione was found to be pesticidal against yellow mealworm pupae (tenebrio) at a concentration of 3 micrograms per insect, against dock beetle larvae at micrograms per insect and against yellow fever mosquito larvae at 6.6 ppm in water.

In the silica gel chromatographic procedure of Example 8, the early eluates (pentane containing 30 percent benzene) brought out a non-polar fraction which was rechromatographed on 125 g. of silica gel and eluted with pentane and with pentane containing increasing amounts of benzene. Pentane with 4% benzene brought out 3.27 g. of 3-methyl-6-(3,4-methylenedioxyphenyl)- l,3-hexadiene [Xa; R is CH as a faintly yellow mobile oil.

Anal. Calcd. for C H O C, 77.75; H, 7.46. Found: C, 78.51; H, 7.46. IR (oil film) 1 3.455 shldrs. (CH); 6.11m, 6.24ms, 6.66s, 6.74s (arom); 6.94s (CH).'

3-Methyl-6-( 3 ,4-methylenedioxyphenyl)-l ,3-hexadiene was found to be pesticidal against dock beetle larvae, yellow fever mosquito larvae, rhodnius prolixus nymph and saltmarsh caterpillar eggs.

EXAMPLE 9 4-[3-Ethyl-6-(3,4-methylenedioxyphenyl)hexyl]-3,5- heptanedione [1; Ar is 3,4-methylenedioxyphenyl, R is H, R and R" are CH CH CO, Y is CH(C H )CH CH CH A mixture of 2.1 g. of 4-[3-ethyl-6-(3,4-methylenedioxyphenyl)-3-hexenyl]-3,5-heptanedione (Example l) and 10.2 g. of palladium-on-carbon catalyst in 50 ml. of absolute ethanol was hydrogenated for two and onehalf hours. The reaction mixture was filtered and concentrated to remove the solvent. The residue was chromatographed on 75 g. of silica gel in benzene-pentane (1:1). The column was eluted with the pentane-benzene-ether solvent sequence, and benzene containing 1% ether brought out the desired product, affording 2.1 g. of 4-[3-ethyl-6-(3,4-methylenedioxyphenyl)hexyl]- 3,5-heptanedione as a colorless oil.

Anal. Calcd. for C H O C, 73.30; H, 8.95. Found: C, 73.20; H, 9.00. C, 73.07; H, 8.82.

[R (oil film) A "ff 3.44s shldrs. (CH), 5.80s, 5.90s (C=O), 6.24m, 6.73s, 6.66 shldr., 6.94s, 6.82 shldr. (arom and CH). NMR (5% CDCI internal TMS) 8 ppm (Ratio) 6.36.8(3) (arom); 5.86(2) (O- CH O); 3.56(l) [(O=C) CH triplet]; 0.7-2.7(30) (CH X 8, Me triplet X 3).

4-[3-Ethyl-6-(3,4-methylenedioxyphenyl)hexyl]-3,5- heptanedione was found to have a minimum inhibitory concentration in vitro against rhino-2, equine rhino, para-influenza and resp. syn. virus of 3 micrograms per milliliter.

4-[3-Ethyl-6-(3,4-methylenedioxyphenyl)hexyl]-3,5- heptanedione was found to be pesticidal against yellow mealworm pupae (tenebrio) at a concentration of 0.3 micrograms per insect.

EXAMPLE 1O 4-[6-(3,4-Methylenedioxyphenyl)hexyl]-3,5-heptanedione [1; Ar is 3,4-methylenedioxyphenyl, R" is H, R and R are CH CH CO, Y is CH CH CH CH was prepared by hydrogenation of 29 g. of 4-[6-(3,4- methylenedioxyphenyl)-3-hexenyl]-3,5-heptanedione (Example 7) according to the procedure described above in Example 9. There was thus obtained 17.2 g. of 4-[6-(3,4-methylenedioxyphenyl)-hexyl]-3,S-hep- [(O=C) CH-triplet]; 2.2-2.7(6) (COCH X 2, arom ring-CH 0.85-2.2(16) (CH, incl. Me triplet X 2). 4-[6-(3,4-Methylenedioxyphenyl)hexyl]-3,5-heptanedione was found to have a minimum inhibitory concentration in vitro of 3 micrograms per milliliter against equine rhino virus.

EXAMPLE 1 l 4-[6-(3,4-Dimethoxyphenyl)-3-ethyl-3-hexenyl]-3,5- heptanedione [1; Ar is 3,4-(CH O) C H R is H, R and R are CH CH CO, Y is C(C H )=CHCH CH was prepared from 10 g. of 3-ethyl-6-(3,4-dimethoxyphenyl)-3-hexenyl iodide (Preparation D4) and 10 g. of the lithium salt of 3,5-heptanedione in m1. of dimethylformamide according to the procedure described above in Example 2, affording 6 g. of 4-[6-(3,4- dimethoxyphenyl)-3-ethyl-3-hexenyl]-3,5-heptanedione as an amber oil.

Anal. Calcd. for C H O C, 73.76; H, 9.15. Found: C, 73.72; H, 9.06.

4-[ 6-( 3 ,4-Dimethoxyphenyl)-3-ethyl-3-hexenyl]-3 ,5- heptanedione was found to be pesticidal against yellow mealworm pupae (tenebrio) at a concentration of 10 micrograms per insect and against dock beetle larvae at a concentration of 20 micrograms per insect.

EXAMPLE 12 4-[6-(4-Methoxyphenyl)-3-hexenyl]-3,S-heptanedione [l; Ar is 4-CH OC H R is H, R and R" are CH CH CO, Y is CH=CHCH CH was prepared from 28.2 g. of 6-(4-methoxyphenyl)-3-hexenyl iodide (Preparation D5) and 19 g. of the lithium salt of 3,5- heptanedione in 250 ml. of dimethylformamide according to the procedure described above in Example 2, affording 19 g. of 4-[6-(4-mcthoxyphenyl)-3-hexenyl]- 3,5-heptanedione as a pale yellow oil, b.p. 162-l67C. (0.04 mm.).

Anal. Calcd. for C H O C, 75.89; H, 8.91. Found: C, 75.92; H, 8.95. IR (oil film) (C=O); 6.22m, 6.80-6.95ms (CH).

NMR (20% CDCI internal TMS) 8 ppm (Ratio) 6.677.2(4) (arom); 5.35(2) (=CH X 2); 3.73, 358(4), [OCH (O=C) -CH triplet]; 1.7-2.9(12) (other aliph. CH); 1.00(6) (Me triplet X 2).

4-[6-(4-Methoxyphenyl)-3-hexenyl]-3,5-heptanedione was found to have a minimum inhibitory concentration in vitro of 3 micrograms per milliliter against equine rhino virus.

EXAMPLE 13 4-[6-(4-Methoxyphenyl)hexyl]-3,5-heptanedione [1; Ar is 4-CH OC H R is H, R and R" are CH CH CO, Y is CH CH CH CH was prepared from 19.1 g. of 6- (4-methoxyphenyl)hexyl iodide (Preparation D6) and 12.8 g. of the lithium salt of 3,5-heptanedione in ml. of dimethylformamide, affording 12.5 g. of 4-[6-(4- methoxyphenyl)hexyl]-3,5-heptanedione as a pale yelfl 3.37-3.53s (CH); 5.81s, 5.88s 6.33ms, 6.62s (arom ring);

. 25 low oil, b.p. l62l63C. (0.03 mm.).

Anal. Calcd. for C H O C, 75.43; H, 9.50. Found: C, 75.67; H, 9.67.

IR (oil film) A 3.45s, 3.53ms (CH); 5.8lmss, 5.91s (C=O); 6.23m, 6.34m, 6.63vs (arom ring); 6.8ms (CH).

NMR (20% CDCl internal TMS) 8 ppm (Ratio) 6.657.25(4) (arom); 3.73(3) (OCH3); 3.62(1) [(O=C) H triplet]; 2.2-2.7(6) (COCH X 2, CH arom); 2.22.7( 16) (other aliph. CH incl. Me triplets).

4-[6-(4-Methoxyphenyl)hexyl]-3,5-heptanedione was found to have a minimum inhibitory concentration in vitro of 3 micrograms per milliliter against equine rhino virus.

EXAMPLE 14 4-(6-Phenylhexyl)-3,S-heptanedione [1; Ar is C H R is H, R and R" are CH CH CO, Y is CH CH CH CH was prepared from 19.1 g. of 6- phenylhexyl iodide (Preparation D7) and 14.1 g. of the lithium salt of 3,5-heptanedione in 195 ml. of dimethylformamide, affording 11.3 g. of 4-(6-phenylhexyl)-3,5- heptanedione as a pale yellow oil, b.p. 135136C. (0.03 mm.).

Anal. Calcd. for C H O C, 79.12; H, 9.78. Found: C, 79.49; H, 9.81.

IR (oil film) A "'3 3.45s, 3.34, 3.40, 3.52 shldrs. (CH); 5.81mss, 5.91s (C=O); 6.26m, 6.33m, 6.69m (arom ring); 6.88ms (CH).

NMR (20% CDCI internal TMS) 8 ppm (Ratio) 7.l(5) (phenyl); 3.60(1) [(O=C) CH triplet]; 2.1-2.8(6) (C=O-CH X 2, mom-CH2); 1.8-2.1(16) (aliph. CH incl. Me triplet X 2).

4-(6-Phenylhexyl)-3,5-heptanedione was found to have a minimum inhibitory concentration in vitro of 6 micrograms per milliliter against equine rhino virus.

EXAMPLE 4-[6-(4-Chlorophenyl)hexyl]-3,5-heptanedione [1; Ar is 4-ClC H.,, R is H, R and R are CH CH CO, Y is CH CH Cl-1 C1-1 was prepared from 21 g. of 6-(4- chlorophenyl)hexyl iodide (Preparation D8) and 13.9 g. of the lithium salt of 3,5-heptanedione in 190 ml. of dimethylformamide, affording 13.5 g. of 4-[6-(4- chlorophenyl)-hexyl]-3,S-heptanedione as a pale yellow oil, b.p. 159-160C. (0.03 mm.).

Anal. Calcd. for C H ClO C, 70.68; H, 8.43. Found: C, 70.86; H, 8.49.

IR (oil film) A if 3.44s, 3.38, 3.52 shldrs. (CH); 5.8lmss, 5.90s (C=O); 6.38m, 6.71s (arom ring); 6.86ms, 6.93 shldr. (CH). NMR CDCl internal TMS) '6 ppm (Ratio) 6.8-7.3(4) (arom); 3162(1) [(O=C) CH triplet]; 2.2-2.7(6) (CO-CH X 2, arom- CH 0.8-2.0(16) (other aliph. CH incl. Me triplet X 2).

4-[6-(4-Chlorophenyl)hexyl]-3,5-heptanedione was found to have a minimum inhibitory concentration in vitro of 1.5 micrograms per milliliter against equine rhino virus.

4-[6-(4-Chlorophenyl)hexyl]-3,5-heptanedione can also be prepared by heating 6-(4-chlorophenyl)hexyl bromide (Preparation C13) with the lithium salt of 3,5- heptanedione in dimethylformamide at 100C.

EXAMPLE 16 4-[6-(p-Tolyl)hexyl]-3,5-heptanedione [1; Ar is 4- CH C H,, R is H, R and R" are CH CH CO, Y is CH CH CH CH was prepared from 6-(p-tolyl)hexyl iodide (Preparation D9) and the lithium salt of 3,5- heptanedione according to the procedure of Example 8, and was obtained in the form of a pale yellow oil, b.p. -146C. (0.01 mm.).

Anal. Calcd. for C H O C, 79.42; H, Found: C, 79.58; H, 10.11.

4-[6-(p-Tolyl)hexyl]-3,5-heptanedione was active against equine rhino virus in vitro at 12 micrograms per milliliter.

1R(oil film) A if 3.435, 3.38 shldr., 3.51mss (CH); 5.81s, 5.89s (C=O); 6.33m, 6.61ms (arom); 6.86mss shldrs. (CH).

EXAMPLE 17 4-[3-Ethyl-6-(4-carbomethoxyphenyl)-3-hexenyl]- 3,5-heptanedione [1; Ar is 4-CH O CC H.,, R is H, R and R" are CH CH CO, Y is C(C H )=CHCH CH was prepared from 14 g. of 3-ethyl-6-( 4-carbomethoxyphenyl)-3-hexenyl iodide (Preparation D10) and 14 g. of the lithium salt of 3,5-heptanedione in 200 ml. of dimethylformamide according to the procedure described above in Example 2. The product was chromatographed on silica gel and eluted with the pentanebenzene-ether solvent series. Benzene containing 2% ether brought out the desired product, 2.6g. of 4-[3- ethyl-6-(4-carbomethoxyphenyl)-3-hexenyl]-3,S-heptanedione as a yellow oil.

Anal. Calcd. for C H O C, 74.16; H, 8.66. Found: C, 74.14; H, 8.53. C, 74.41; H, 8.69.

IR (oil film) A a 3.44mss shldrs. (CH); 5.77s 5.90 shldr. (C=O); 6.24mms, 6.35m, 6.63w; 6.87mms, 6.98ms (arom CH).

NMR (20% CDCl internal TMS) 6 ppm (Ratio) 8.00(2), 7.25(2) (arom); 5.10(1 (=CH); 3.88(3) (OMe); 3.61(1) [(O=C) CH], 0.7-3.0(22) (aliph. CH incl. Me triplets).

4-[3-Ethyl-6-(4-carbomethoxyphenyl)-3-hexenyl]- 3,5-heptanedione was found to have a minimum inhibitory concentration in vitro of 25 micrograms per milliliter against equine rhino virus.

4-[3-Ethyl-6-(4-carbomethoxyphenyl)-3-hexenyl]- 3,5-heptanedione was found to be pesticidal against dock beetle larvae at a concentration of l microgram per insect.

EXAMPLE l8 4-[3-Ethyl-6-(3,4-methylenedioxyphenyl)-3,S-hexadienyl]-3,S-heptanedione [1; Ar is 3,4-methylenedioxyphenyl, R" is H, R and R are CH CH CO, Y is C(C H )=CHCH=CH] was prepared from 10.5 g. of 3-ethyl-6-( 3 ,4-methylenedioxyphenyl )-3 ,S-hexadienyl iodide (Preparation D11) and 10 g. of the lithium salt of 3,5-heptanedione in ml. of dimethylformamide. The product was chromatographed on silica gel and the impurities removed by elution with pentane-benzene (1:1). The desired product was brought out by elution with chloroform-benzene (6:4), affording 2 g. of 4-[3- ethyl-6-( 3 ,4-methylenedioxyphenyl)-3 ,5-hexadienyl1- 3,5-heptanedione as an amber oil.

Anal. Calcd. for C H O C, 74.13; H, 7.92. Found: C, 74.26; H, 7.91.

4-[3-Ethyl-6-(3,4-methylenedioxyphenyl)-3,5-hexadienyl]-3,S-heptanedione was found to have a minimum inhibitory concentration in vitro of 6 micrograms per milliliter against equine rhino virus.

4-[3-Ethyl-6-(3,4-methylenedioxyphenyl)-3,S-hexadienyl]-3,5-heptanedione was found to be pesticidal against yellow mealworm pupae (tenebrio) at a con- 27 centration of micrograms per insect and against dock beetle larvae at a concentration of micrograms per insect.

By procedures similar to those described above 3-isopropyl-6-(3,4-methylenedioxyphenyl)hexyl iodide, 3- butyl-6-(3,4-methylenedioxyphenyl)hexyl iodide, 6- (3,4-dichlorophenyl)hexyl iodide, 6-(2,4-dichlorophenyl)hexyl iodide, 6-(4-bromophenyl)hexyl iodide, 6-(4-fluorophenyl)hexyl iodide, 6-(4-benzoyloxyphenyl)-3-hexenyl iodide, 6-(4-trifluoromethoxyphenyl)hexyl iodide, or 6-(4-trifluoromethylphenyl)- hexyl iodide can be caused to react with the lithium salt of 3,5-heptanedione to give, respectively, 4-[3-isopropyl-6-(3,4-methylenedioxyphenyl)hexyl]-3,5-heptanedione [1; Ar is 3,4-methylenedioxyphenyl, R is H, R and R" are CH CH CO, Y is CH(C H )CH CH CH 4-[3-butyl-6-(3,4-

methylenedioxyphenyl)hexyl]-3,5-heptanedione [1; Ar is 3,4-methylenedioxyphenyl, R is H, R and R are CH CH CO, Y is CH(C H )CH CH CH 4-[6-(3,4- dichlorophenyl)hexyl]-3,5-heptanedione [1; Ar is 3,4Cl C H R is H, R and R" are CH CH CO, Y is CH CH Ch CH 4-[6-(2,4-dichlorophenyl)hexyl]- 3,5-heptanedione [1; Ar is 2,4-Cl C H R is H, R and R are CH CH CO, Y is CH CH C1-l CH 4-[6-(4- bromophenyl)hexyl]-3,5-heptanedione [1; Ar is 4- BrC H R is H, R and R are CH CH CO, Y is CH CH CH CH 4-[6-(4-fluorophenyl)hexyl]-3,5- heptanedione [1; Ar is 4-FC H R is H, R and R are CH CH CO, Y is CH CH CH CH l, 4-[6-(4-benzoyloxyphenyl)-3-hexenyl]-3,5-heptanedione [1; Ar is 4-C H COOC H,, R is H, R and R" are CH CH CO, Y is CH=CHCH CH L 4-[6-(4-trifluoromethoxyphenyl)hexyl]-3,5-heptanedione [1; Ar is 4-F COC H.,, R is H, R and R" are CH CH CO, Y is CH CH CH CH or 4-[6-(4-trifluoromethylphenyl)hexyl]-3,5-heptanedione [1; Ar is 4-F CC H R is H, R and R are CH CH CO, Y is CH CH CH CH 4-[6- (4-Benzoyloxyphenyl)-3-hexenyl]-3,5-heptanedione can be saponified with methanolic potassium carbonate to produce 4-[6-(4-hydroxyphenyl)-3-hexenyl]-3,5- heptanedione [1; Ar is 4-HOC H R is H, R and R" are CH CH CO, Y is CH=CHCH CH EXAMPLE 19 4-Chloro-4-[3-ethyl-6-(3,4-methylenedioxyphenyl)- 3-hexenyl]-3,5-heptanedione [1; Ar is 3,4-methylenedioxyphenyl, R" is Cl, R and R" are CH CH CO, Y is C(C H )=CHCH,CH

A solution of 3.1 g. (0.193 mole) of cupric chloride dihydrate and 1.5 g. of lithium chloride in 60 ml. of dimethylformamide was warmed to 90C. and 6.0 g. (0.0167 mole) of 4-[3-ethyl-6-(3,4-methylenedioxyphenyl)-3-hexenyl]-3,5-heptanedione (Example 1) was added. The reaction mixture was stirred at 90C. for two hours, then cooled and concentrated in vacuo to remove the solvent. The residual oil which still contained some starting material was treated again with 2.47 g. of cupric chloride and 1.2 g. of lithium chloride in 40 ml. of dimethylformamide, two hours at 90C. The product was isolated and chromatographed on 150 g. of silica gel in 50% benzene-pentane. The column was eluted with the same solvent and then with pentane containing increasing proportions of benzene. The desired product was brought out with 65-75% benzene to give 2.95 g. of 4-chloro-4-[3-ethyl-6-(3,4-methylenedioxyphenyl)-3-hexenyl]-3,5-heptanedione as a light yellow liquid.

mum inhibitory concentrations in vitro against rhino-2,

para-influenza and resp. syn. virus of 1.25, 12 and 12 micrograms per milliliter, respectively.

4-Ch1oro-4-[3-ethyl-6-(3,4-methylenedioxyphenyl)- 3-hexenyl]-3,5-heptanedione was found to be pesticidal against yellow mealworm pupae (tenebrio) at a concentration of 0.3 micrograms per insect and against dock beetle larvae at 5 micrograms per insect.

EXAMPLE 2O 4-Methyl-4-[3-ethyl-6-(3,4-methylenedioxyphenyl)- 3-hexenyl]-3,5-heptanedione [1; Ar is 3,4-methylenedioxyphenyl, R is CH R and R are CH CH CO, Y is C(C H )=CHCH CH A solution of 6.4 g. (0.042 mole) of 1,5-diazabicyclo- [5.4.0]undec-5-ene and 5.0 g. (0.014 mole) of 4-[3- ethyl6-(3,4-methylenedioxyphenyl)-3-hexenyl]-3,5-

heptanedione (Example 1) in 50 ml. of absolute ethanol was stirred on an oil bath at 4550C. Methyl iodide (4.0 g., 0.028 mole) in 10 ml. of ethanol was added dropwise over a twenty minute period. During three hours, four additional equivalents of 1,5- diazabicyclo[5.4.0]undec-5-ene and five more equivalents of methyl iodide were added alternately. The mixture was added to 400 ml. of ether, and the ether was extracted with water, dried over anhydrous magnesium I sulfate and concentrated. The residue which still contained some starting material was again treated with three equivalents of l,5-diazabicyclo[5.4.0]undec- S-ene and one equivalent of methyl iodide in ethanol. After the reaction was complete, the product was isolated and chromatographed on silica gel (3.75 g.) using benzene in pentane. The product was eluted with 75% benzene and then with pure benzene; the latter benzene fractions brought out the desired product, affording 1.5 g. of 4-methyl-4-[3-ethyl-6-(3,4- methylenedioxyphenyl)-3-hexenyl ]-3 ,S-heptanedione as a light yellow oil.

Anal. Calcd. for C H O C, 74.16; H, 8.66. Found: C, 74.62; H, 8.71. C, 74.85; H, 8.50.

IR (oil film) A "'5 3.39, 3.42s, 3.48, 3.61 shldrs. (CH); 5.89s, 5.82 shldr. (C=O); 6.22m, 6.65mss, 6.71s, 6.85mss, 6.93s (arom and CH).

NMR (20% CDCl internal TMS) 8 ppm (Ratio) 6.75(3) (arom); 5.97(2) (O-CH -O); 5.22(1) (=CH); 1.7-2.9(14) (CH X 7); 2.l8(3) (Me singlet); 0.7-1.2(9) (Me triplet X 3).

4-Methyl-4-[3-ethyl-6-(3,4-methylenedioxyphenyl)- 3-hexenyl]-3,5-heptanedione was found to have minimum inhibitory concentrations in vitro against rhino-2, equine rhino, para-influenza and resp. syn. virus of 0.6, 1.5, 6 and 6 micrograms per milliliter, respectively.

4-Methyl-4-[3-ethyl-6-(3,4-methylenedioxyphenyl)- 3-hexenyl]-3,5-heptanedione was fouond to be pesticidal against yellow mealworm pupae (tenebrio) at a concentration of 10 micrograms per insect.

By replacing the methyl iodide in the foregoing preparation by isopropyl iodide or n-butyl iodide there can be obtained, respectively, 4-isopropyl-4 -[3-ethyl-6- 29 (3,4-methylenedioxyphenyl)-3-hexenyl]-3,5-heptanedione [1; Ar is 3,4-methylenedioxyphenyl, R is (CH CH, R and R" are CH CH CO, Y is C(C H )=CHCH CH or 4-(n-butyl)-4-[3-ethyl-6- (3,4-methylenedioxyphenyl)-3-hexenyl]-3,S-heptanedione [1; Ar is 3,4-methylenedioxyphenyl, R is CH CH CH CH R and R" are CH CH CO, Y is C(C H )=CHCH CH According to the procedures described in the foregoing examples, the following compounds were also prepared:

EXAMPLE 21 4-[6-(p-Tolyl)-3-hexenyl]-3,S-heptanedione [1; Ar is 4-CH C H R is H, R and R are CH CH CO, Y is CH=CHCH CH was prepared from the compound of Preparation D23 and the lithium salt of 3,5-heptanedione, and obtained as a pale yellow oil, b.p. 147149C.(0.02 mm.).

Anal. Calcd. for C H O C, 79.95; H, 9.39. Found: C, 80.17; H, 9.43.

IR (oil film) A "if 3.45mss shldrs., 3.40, 3.52 (CH); 5.81s, 5.91s (C=O); 6.34m, 6.25 shldr., 6.62ms (arom); 6.88ms shldrs. (CH).

4-[6-(p-Tolyl)-3-hexenyl]-3,5-heptaneclione can be hydrogenated catalytically to produce the compound of Example 16.

EXAMPLE 22 4-[6-(2,4-Dichlorophenyl)hexyl]-3,5-heptanedione [1; Ar is 2,4-Cl C H R is H, R and R" are CH CH CO, Y is CH CH Ch- CH was prepared from the compound of Preparation D12 and the lithium salt of 3,5-heptanedione, and obtained as a clear orange liquid, b.p. 179181C. (0.3 mm.).

Anal. Calcd. for C H Cl O C, 63.87; H, 7.33; Cl, 19.84. Found: C, 64.17; H, 7.42; Cl, 19.83.

IR (oil film) A "5 3.43mss, 3.38 shldr., 3.51ms (CH); 5.805, 5.895 (C=O); 6.36mms, 6.41m, 6.80s shldrs. (arom CH).

4-[6-(2,4-Dichlorophenyl)hexyl]-3,5-heptanedione was active against equine rhino virus in vitro at 3 micrograms per milliliter.

EXAMPLE 23 4-[6-(4-Acetamidophenyl)-3-hexenyl]-3,5-heptanedione [1; Ar is 4-CH CONHC H R is H, R and R are CH CH CO, Y is CH=CHCH,CH was prepared from the compound of Preparation D13 and the lithium salt of 3,5-heptanedione, and obtained as a viscous amber oil, b.p. 2l5-220C. (0.02 mm.).

Anal. Calcd. for C H NO C, 73.44; H, 8.51; N, 4.08. Found: C, 72.95; H, 8.45; N, 4.43.

IR (oil wilm))\ shldrs. (CH); 5.85, 5.97, 6.06s (C=O, N-C=O); 6.30s, 6.57s, 6.65s, 6.93, 7.00 shldr. (arom CH).

4-[6-(4-Acetamidophenyl)-3-hexenyl]-3,5-heptanedione was active against equine rhino virus in vitro at 12 micrograms per milliliter.

EXAMPLE 24 4-[8-(4-Methoxyphenyl)-3,7-octadienyl]-3,5-heptanedione [1; Ar is 4-CH OC H.,, R is H, R and R are CH CH CO, Y is CH=CHCH CH CH=CH] was prepared from the compound of Preparation D14 and the lithium salt of 3,5-heptanedione, and obtained as a pale yellow oil, b.p. 184-186C. (0.03 mm.).

Anal. Calcd. for C H O C, 77.15; H, 8.83. Found: C, 76.82; H, 8.84.

IR (oil film) A a 3.42mss+shldrs. (CH); 5.78ms, 5.89ms (C=O); 6.23mms, 6.32m, 6.62s (arom); 6.85mms shldrs. (CH).

4-[8-(4-Methoxyphenyl)-3,7-octadienyl]-3,S-heptanedione was active against equine rhino virus in vitro at 6 micrograms per milliliter. It was also active against para-influenza virus and several strains of human rhino virus at 1.5 micrograms per milliliter.

EXAMPLE 25 4-[8-(4-Methoxyphenyl)octyl]-3,5-heptanedione [1; Ar is 4-CH OC H R is H, R and R are CH CH CO, Y is CH CH CH CH CH CH was prepared by catalytic hydrogenation (PtO of the compound of Example 24, and obtained as a pale yellow oil, b.p.

176177C.(0.02 mm Anal. Calcd. for C H O C, 76.26; H, 9.89. Found: C, 76.05; H, 9.83.

IR (oil film) A "if 3.44s, 3.51 ms (CH); 5.79ms, 5.89s (C=O); 6.2lmms, 6.32m, 6.61s (arom); 6.89ms (CH).

4-[8-(4-Methoxyphenyl)octyl]-3,5-heptanedione was active against equine rhino virus in vitro at 12 micrograms per milliliter.

EXAMPLE 26 4-[6-(4-Dimethylaminophenyl)-3-hexenyl]-3,5-heptanedione [1; Ar is 4-(CH NC H R is H, R and R are CH CH CO, Y is CH=CHCH CH was prepared from the compound of Preparation D15 and the lithium salt of 3,5-heptanedione, and obtained as a pale yellow oil, b.p. 155159C. (0.003 mm.).

Anal. Calcd. for C H NO C, 76.55; H, 9.48; N, 4.25. Found: C, 77.04; H, 9.63; N, 4.61.

IR (oil film) A [1 3.438 shldrs., 3.53ms (CH); 5.79, 5.89s (C=0); 6.26ms, 6.32 shldr., 6.39m, 6.57s, 6.76m, 6.90ms (arom CH).

4-[6-(4-Dimethylaminophenyl)-3-hexenyl]-3,S-heptanedione was active against equine rhino virus in vitro at 3 micrograms per milliliter. It was also active against the para-influeza virus and several strains of human I rhino virus at 1.5-7 micrograms per milliliter.

"[1" 3.l2ms+ shldrs. (NH); 3.50ms

EXAMPLE 27 4-[6-(4-Benzyloxyphenyl)-3-hexenyl]-3,5-heptanedione [1; Ar is 4-C H C1-l OC H R is H, R and R" are CH CH CO, Y is CH=CHCH CH was prepared from the compound of Preparation D16 and the lithium salt of 3,5-heptanedione, and obtained as a colorless solid, mp 3637C. when recrystallized from ether.

Anal. Calcd. for C H O C, 79.56; H, 8.22. Found: C, 79.51; H, 8.31. 4-[6-(4-Benzyloxyphenyl)-3-hexenyl]-3,5-heptanedione was active against equine rhino virus in vitro at 3 micrograms per milliliter. It was also active against two strains of human rhino virus at 0.3 micrograms per milliliter.

EXAMPLE 28 4-[6-(4-Hydroxyphenyl)hexyl]-3,5-heptanedione [1; Ar is 4-HOC H R is H, R and R" are CH Ch CO, Y is CH CH CH CH was prepared by hydrogenation of 21.4 g. of 4-[6-(4-benzyloxyphenyl)-3-hexeny1]-3,5- heptanedione in the presence of 2.5 g. of 10% palladium-on-carbon catalyst in 200 ml. of absolute ethanol. Hydrogenation was complete in three hours, and the product was isolated and recrystallized from isopropyl alcohol to give 11.5 g. of 4-[6-(4-hydroxyphenyl)hexyl]-3,5-heptanedione, m.p. 7677C.

Anal. Calcd. for C H O C, 74.96; H, 9.27. Found: C, 74.93; H, 9.30.

4-[6-(4-Hydroxyphenyl)hexyl]-3,5-heptanedione was active against equine rhino virus in vitro at 12 micrograms per milliliter. It was also active against parainfluenza virus and two strains of human rhino virus at 6-12 micrograms per milliliter.

EXAMPLE 29 4-[6-(3,4-Dihydroxyphenyl)hexyl]-3,5-heptanedione [I; Ar is 3,4-(HO) C H R is H, R and R are CH CH CO, Y is CH CH CH CH was prepared from the compound of Preparation D17 and the lithium salt of 3,5-heptanedione, followed by catalytic hydrogenation of the resulting 4-[6-(3,4-dibenzyloxyphenyl)-3- hexenyl]-3,5-heptanedione. It was obtained as an amber oil after chromatography.

Anal. Calcd. for C H O C, 71.22; H, 8.81. Found: C, 69.61 H, 8.71.

IR (oil film) A "'1? 2.96mss (OH); 3.44mss, 3.52ms shldr. (CH); 5:80-5.93s (C=O); 6.25ms, 6.60mss, 6.83- 6.95ms (arom CH).

4-[6-(3,4-Dihydroxyphenyl)hexyl]-3,S-heptanedione was active against equine rhino virus in vitro at 1.5 micrograms per milliliter. It was also active against para-influenza virus at 6, and against two strains of human rhino virus at 0.3 and 1.5 micrograms per milliliter.

EXAMPLE 30 4-[6-(4-Trifluoromethoxyphenyl)-3-hexenyl]-3,5- heptanedione [1; Ar is 4-F COC H R is H, R and R" are CH CH,CO, Y is CH=CHCH CH,] was prepared from the compound of Preparation D18 and the lithium salt of 3,5-heptanedione, and obtained as a yellow oil, b.p. 138140C.(0.05 mm.).

Anal. Calcd. f0! C20H25F303: C, H, F, 15.38. Found: C, 65.03; H, 6.88; F, 15.63.

[R (oil film) A ""ff 3.43mss. 3.38 shldr. (CH); 5.79s, 5.89s (C=O); 6.31m. 6.63mss (arom), 6.87ms shldrs. (CH).

4-[6-(4-Trifluoromethoxyphenyl)-3-hexenyl]-3,5- heptanedione was active against equine rhino virus in vitro at 6 micrograms per milliliter.

EXAMPLE 31 4-[6-(4-Trifluoromethoxyphenyl)hexyl]-3,5-heptanedione [1; Ar is 4-F COC H R is H, R and R are CH CH CO, Y is CH CH Cl-l CH was prepared by catalytic hydrogenation of the compound of Example 30, and obtained as a light yellow oil, b.p. l24l 27C. (0.001 mm.).

Anal. Calcd. for C H F O C, 64.50; H, 7.30; F, 15.30. Found: C, 64.44; H, 7.37; F, 15.22.

[R (oil film) A 3.42s, 3.38 shldr., 3.50ms (CH); 5.78s, 5.88s (C=O); 6.30m, 6.62mss (arom), 6.84ms shldr. (CH).

4-[6-(4-Trifluoromethoxyphenyl)hexyl]-3,5-heptanedione was active against equine rhine virus in vitro at 6 micrograms per milliliter.

EXAMPLE 32 l-Naphthyl)hexyl]-3,5-heptanedione [1; Ar is l-naphthyl, R is H, R and R are CH CH CO, Y is CH CH CH CH was prepared from the compound of Preparation D19 and the lithium salt of 3,5-heptanedione, and obtained as a pale yellow oil, b.p. 185187C. (0.005 mm.).

Anal. Calcd. for C H O C, 81.61; H, 8.93. Found: C, 81.55; H, 8.99.

IR (oil film) M 3.44s, 3.30m, 3.52ms (CH); 5.81s, 5.90s (C=O); 6.29m, 6.33 shldr., 6.63m (arom); 6.85 shldr. (CH).

4-[6-(b1-Naphthyl) hexyl]-3,5-heptanedione was active against equine rhino virus in vitro at 6 micrograms per milliliter.

EXAMPLE 33 EXAMPLE 34 4-8 6-(4-Hydroxy-3,S-dimethoxyphenyl)hexyl]-3,5-

heptanedione [1; Ar is 3,5-(CH O) -4-HOC H R is H,

R and R are CH CH CO, Y is CH CH CH CH yellow oil, was prepared from the compound of Preparation D22 and the lithium salt of 3,5-heptanedione, followed by catalytic hydrogenation of the resulting 4-[6- (4-benzyloxy-3,S-dimethoxyphenyl)-3-hexenyl]-3,5- heptanedione (light yellow oil).

EXAMPLE 35 a. 7-(4-Methoxyphenyl)heptyl phenyl sulfide.

Phenyllithium (378 ml., 0.755 mole) was added over a period of 2-5 minutes to a solution of 94.5 g. of thioanisole in 600 ml. of tetrahydrofuran, stirred under nitrogen. The mixture was stirred at room temperature for about l6'hours, then cooled to --C. (solid CO and 141 g. of 6-(4-methoxyphenyl)hexyl iodide in 210 ml. of tetrahydrofuran was added slowly. The reaction mixture was stirred at 65C. for two hours and then allowed to warm to room temperature. Water was added and the mixture extracted with pentane. The pentane extracts were washed with water, dried and concentrated to remove the solvent. The residue was distilled in vacuo, b.p. 17l174C. (0.15 mm.). The distillate crystallized and was recrystallized from pen tane, to give 7-(4-methoxyphenyl)heptyl phenyl sulfide, m.p. 5859C.

b. 7-(b4-Methoxyphenyl)heptyl iodide.

A mixture of 34 g. of 6-(4-methoxyphenyl)heptyl phenyl sulfide, 156 g. of methyl iodide and 30 g. of sodium iodide in ml. of dimethylformamide was refluxed for 88 hours, additional quantities (50 ml., 70 ml. and 30 ml.) of methyl iodide being added each successive day. The reaction mixture was partitioned between water and pentane, the pentane layer separated and washed with water, dried and concentrated. The residue (46.7 g.) was distilled in vacuo, b.p. 129139C. (0.03 mm. to give 13.0 g. of 7-(b 4- methoxyphenyl)heptyl iodide.

c. 4-[7-(4-Methoxyphenyl)heptyl]-3,S-heptanedione [1; Ar is 4-CH OC H R is H, R and R are CH CH CO, Y is CH CH CH CH CH was prepared from 7-(4-methoxyphenyl)hepty] iodide and the lithium salt of 3,5-heptanedione, and obtained as a pale yellow oil, b.p. 169l71C.(0.02 mm.).

Anal. Calcd. for c r-[ 0,1 C, 75.86; H, 9.70. Found: C, 75.77; H, 9.62.

By replacing the 6-(4-methoxyphenyl)hexyl iodide in part (a) of the foregoing example by a molar equivalent amount of 8-(4-methoxyphenyl)-3,7-octadienyl iodide and performing the transformations of the remainder of the example, there can be obtained 4-[8-(4-methoxyphenyl)-4,8-nonadienyl]-3,5-heptanedione [1; Ar is 4- CH OC H R is H, R and R" are CH CH CO, Y is CH CH=CHCH CH CH=CHL EXAMPLE 36 a. Diethyl [6-(4-benzyloxyphenyl)-3-hexenyl]malonate.

A mixture of 205.8 g. of 6-(4-benzyloxyphenyl)-3- hexenyl iodide (Preparation d16) and 171 g. of the lithium salt of diethyl malonate in 1650 ml. of dimethylformamide was heated at 5060C. for 16 hours. The reaction mixture was concentrated to dryness, the residue partitioned between water and ether, and the ether layer washed with sodium chloride solution, dried and concentrated to give'226 g. of diethyl [6-(4-benzyloxyphenyl)-3-hexenyl]malonate, used in the next reaction without further purification.

I b. 8-(4-Benzyloxyphenyl)-5-octenoic acid [4- C H CH OC H CH CH -CH=CHCH CH CH COOH A mixture of 222 g. of diethyl [6-(4-benzyloxyphenyl)-3-hexenyl]malonate, 286 g. of 85% potassium hydroxide and 510 ml. of water was refluxed for two hours. The reaction mixture was cooled, acidified with hydrochloric acid and extracted with chloroform. The chloroform extracts were dried and concentrated, and the residue was dissolved in 600 ml. of xylene and heated at reflux for about 16 hours. The solution was cooled, the solvent removed in vacuo, and the residue crystallized from cyclohexanepentane to give 110 g. of

8-(4-benzyloxyphenyl)-5 -octenoic acid, m.p. 6365C.

A solution of 110 g. of 8-(4-benzyloxyphenyl)-5- octenoic acid in 400 ml. of tetrahydroturan was added dropwise to a slurry of 13.4 g. of lithium aluminum hydride in 630 ml. of tetrahydrofuran at such a rate as to maintain reflux. The reaction mixture was heated at reflux for four hours, then cooled, and 26.5 ml. of tetrahydrofuran and 26.5 ml. of water were added. The solvents were removed in vacuo and the residue crystallized from cyclohexane to give 98 g. of 8-(4-ben zyloxyphenyl)-5-octenol, m.p. 65-67C.

d. 8-(4-Benzyloxyphenyl)-5-octenyl ptoluenesulfonate.

8-(4-Benzyloxyphenyl)-5-octenol (24 g.) was added in portions over a minute period to a solution of 19.5 g. of p-toluenesulfonyl chloride in 600 ml. of dry pyridine at -10C. The reaction mixture was stirred for one hour at 10C., then poured into ice-water and stirred for minutes. The mixture was extracted with chloroform, and the latter washed with aqueous hydrochloric acid, aqueous sodium hydroxide, dried and concentrated. The resulting 8-(4-benzyloxyphenyl)-5- octenyl p-toluenesulfonate was used directly in the next reaction without further purification.

e. 8-(4Benzyloxyphenyl)-5-octenyl iodide cal [5CH2OC H4CHzCH2'cH CHCH2CH2CH2CH2I].

A mixture of 33.2 g. of 8-(4-benzyloxyphenyl)-5- octenyl p-toluenesulfonate, 12.6 g. of sodium iodide and 370 ml. of Z-butanone was heated at reflux for four hours, then filtered and concentrated to remove the solvent. The residue was partitionedbetween ether and water, and the ether solution was washed with aqueous sodium thiosulfate, dried and concentrated to give 26.4 g. of 8-(4-benzyloxyphenyl)-5-octenyl iodide.

f. 4-[8-(4-Benzyloxyphenyl)-5-octenyl]-3,5-heptanedione [I; Ar is 4-C H CH OC H R is H, R and R as CH CH CO, Y is CH CH CH=CHCH CH was prepared from 8-( 4-benzyloxyphenyl)-5-octenyl iodide and the lithium salt of 3,5-heptanedione, and obtained as an oil used directly in the hydrogenation procedure below.

g. 4-[8-(4-Hydroxyphenyl)octyl]-3,5-heptanedione [1; Ar is 4-C H CH C H R is H, R and R are CH CH CO, Y is CH CH CH CH CH CH was prepared by hydrogenating 4[8-(4-benzyloxyphenyl)-5- ocetenyl]-3,S-heptanedione in the presence of palladium-on-carbon catalyst, and obtained as colorless crystals, m.p. 164165C.

Anal. Calcd. for C H O C, 75.86; H, 9.70. Found: C, 75.91; H, 9.78.

4-[8-(4-Hydroxyphenyl)octyl)]-3,5-heptanedione was active against equine rhino virus in vitro at 3 micrograms per milliliter, and against para-influenza virus at 6 and two strains of human rhino virus at 0.3 and 1.5 micrograms per milliliter.

By replacing 6-(4-benzyloxyphenyl)-3-hexenyl iodide in part (a) of the foregoing example by a molar equivalent amount of 8-(4-methoxyphenyl)-3,7-octadienyl iodide (Preparation D14), and performing the transformations of parts (b )-(f) of said example, there can be obtained 4-[ l0-(4-methoxyphenyl)-5,9- decadienyl]-3,5-heptanedione [l; Ar is 4-CH OC H R is H, R and R" are CH CH CO, Y is CH CH CH=CHCH CH CH=CHL which can be hydrogenated to afford 4-[ l0-(4-methoxyphenyl)decyl]- 3,5-heptanedione [1; Ar is 4-CH OC H R is H, R and R are CH CH CO, Y is CH CH CH CH- CH CH CH CH EXAMPLE 37 4-{6-[4-(Methoxybenzoyloxy)phenyl]hexyl}-3,5- heptanedione [1; Ar is 4-CH OC H -COOC H R is H, R and R" are CH CH CO, Y is CH CH CH CH To a solution of 6.8 g. of 4-[6-(4-hydroxyphenyl)- hexyl]-3,5-heptanedione (Example 28) in 30 ml. of dry pyridine was added 7.65 g. of p-anisoyl chloride over a period of 10 minutes. The reaction mixture was stirred overnight at room temperature and then poured into water. The mixture was extracted with ether, and the ether extracts were washed successively with 2N hydrochloric acid, water, 5% aqueous sodium bicarbonate, and water, then dried over anhydrous magnesium sulfate and concentrated. The residue was chromatographed on 270 g. of activated magnesium silicate and eluted with the pentane-benzene-ether solvent series. Benzene-ether 8:2 brought out 4.2 g. of 4-{ 6-[4-(methoxybenzoyloxy)phenyl]hexyl}-3,5-heptanedione as a light yellow solid.

Anal. Calcd. for C H O C, 73.94; H, 7.81. Found: C, 73.53; H, 7.60.

4- {6-[4-(Methoxybenzoyloxy)phenyl]hexyl}-3,5- heptanedione was found to be active in vivo upon intragastral or subcutaneous administration at 200 mg/kg to mice infected with Jap influenza strain, whereby 60% of the medicated mice survived.

EXAMPLE 38 4-{6-[4-(Methylbenzoyloxy )phenyl ]hexyl }-3,5-hepand R" are CH CH CO, Y is CH CH CH CH was prepared from 4-[6-(4-hydroxyphenyl)hexyl]-3,5-heptanedione and p-toluyl chloride according to the procedure of Example 37, and was obtained in the form of offwhite crystals, m.p. 7275C.

Anal. Calcd. for C -,H O C, 76.74; H, 8.1 LFound: C, 76.89; H, 8.11.

EXAMPLE 39 4-[6-(4-Hydroxyphenyl)hexyl]-3,5-heptanedione 4- morpholinobutanoate [l; Ar is 4- A suspension of g. of 4-]6-(4-hydroxyphenyl)hexyl]-3,5-heptanedione (Example 28), 3.45 g. of 4-morpholinobutyric acid hydrochloride and 3.74 g. of dicyclohexylcarbodiimide (DCC) in 50 ml. of methylene dichloride was stirred at room temperature for two days. The solid dicyclohexyl urea was removed by filtration and washed with methylene dichloride. The combined washings and filtrate was concentrated to dryness and the residue triturated with ether to induce crystallization of the product. The latter was collected and dried to give 7.45 g. of 4-[6-(4-hydroxyphenyl)- hexyl]-3,5-heptanedione 4-morpholinobutanoate in the form of its hydrochloride salt, light tan solid, m.p. 57-59C.

Anal. Calcd. for C -,H NO 'HCl: C, 65.37; H, 8.53; N, 2.82; CI, 7.15. Found: C, 65.1 1; H, 8.44; N, 3.08; Cl, 7.37.

By replacing the 4-morpholinobutyric acid hydrochloride in the foregoing preparation by a molar equivalent amount of 4-diethylaminobutyric acid hydrochloride there can be prepared 4-[66-- -(4-hydroxyphenyl)hexyl]-3,5-heptanedione 4-diethylaminobutanoate [1; Ar is 4- is H, R and R are CH CH CO, Y is CH CH CH CH The glycinate ester of 4-[6-(4-hydroxyphenyl)hexyl]-3,5-heptanedione [1; Ar is 4-NH CH COOC H R is H, R and R are CH CH CO, Y is CH CH CH CH can be prepared by reacting the phenolic compound with carbobenzoxyglycine to form the carbobenzoxyglycine ester, and removing the carbobenzoxy group with acetic acid saturated with hydrogen bromide.

4-[6-(4-Hydroxyphenyl)hexyl]-3,5-heptanedione can be caused to react with acetic anhydride, propionic anhydride, caproyl chloride, succinic anhydride, B- cyclopentylpropionyl chloride, p-nitrobenzoyl chloride, 3,4,5-trimethoxybenzoyl chloride, phenylacetyl chloride or cinnamoyl chloride to give, respectively, the acetate, propionate, caproate, hemisuccinate, B- cyclopentylpropionate, p-nitrobenzoate, 3,4,5-trimethoxybenzoate, phenylacetate or cinnamate ester of 4- [6-(4-hydroxyphenyl)hexyl]-3,5-heptanedione.

EXAMPLE 40 a. 4-[6-(3-Benzyloxyphenyl)-3-hexenyl]-3,5-heptanedione [1; Ar is 3-C H CH OC H R is H, R and R are CH CH CO, Y is CH=CHCH CH was prepared according to Reaction Sequence A starting with m-benzyloxybenzaldehyde and cyclopropyl methyl ketone.

b. 4-[6-(3-Hydroxyphenyl)hexyl]-3,5-heptanedione [1; Ar is 3-HOC H R is H, R and R" are CH CH CO, Y is CH CH CH CH was prepared by catalytic hydrogenation of 4-[6-(3-benzyloxyphenyl)-3-hexenyl]-3,5- heptanedione with palladium-on-carbon. The product was chromatographed on silica gel and eluted with ethyl acetate-chloroform 1:9 to give 4-[6-(3-hydroxyphenyl)-hexyl]-3,S-heptanedione as a colorless oil.

Anal. Calcd. for C H O C, 74.96; H, 9.27. Found: C, 74.62; H, 9.34

EXAMPLE 41 a. 3-[6-(4-Benzyloxyphenyl)-3-hexenyl]-2,4-pentanedione [1; Ar is 3-C H CH OC H R is H, R and R are CH CO, Y is CH=CHCH CH was prepared by reacting 6-(4-benzyloxyphenyl)-3-hexenyl iodide (Preparation D16) with lithium pentane-2,4-dione. The product was chromatographed on activated magnesium silicate and eluted with benzene.

b. 3-[6-(4-Hydroxyphenyl)hexyl]-2,4-pentanedione [1; Ar is 3-HOC H R is H, R and R" are CH CO, Y is CH CH CH CH was prepared by catalytic hydrogenation of 3-[6-(4-benzyloxyphenyl)-3-hexenyl]-2,4- pentanedione and had the m.p. 6869C.

Anal. Calcd. for C H O C, 73.88; H, 8.75. Found: C, 74.08; H, 8.80.

EXAMPLE 42 a. 5-(2-Methoxy-4-chlorobenzoyl)pentyl bromide.

Aluminum chloride (70 g.) was added portionwise to a solution of 1 10 g. of 6-bromocaproyl chloride in 250 ml. of methylene dichloride. To the resulting solution was added slowly, with cooling and stirring, 72 g. of mchloroanisole in 250 ml. of methylene dichloride. The reaction mixture was stirred for one hour and poured into 500 ml. of 2N hydrochloric acid and 500 ml. of ice. The organic layer was separated and the aqueous layer extracted with ether. The combined organic layers were washed with sodium bicarbonate solution, dried over anhydrous magnesium sulfate and concentrated. The product containing isomeric mixtures was chromatographed on silica gel and eluted with ethyl acetate-hexane. The first compound eluted (72 g.) was the desired isomer, 5-(2-methoxy-4-chlorobenzoyl)-pentyl bromide.

b. S-Bromopentyl 2-methoxy-4-chlorophenyl carbinol.

Borane in tetrahydrofuran (240 ml. of 1M) was added over a period of 15 minutes to a solution of 72 g. of 5-(2-methoxy-4-chlorobenzoyl)pentyl bromide in 240 ml. of tetrahydrofuran. The mixture was stirred 45 minutes in an ice bath, and then 300 ml. of 2N hydrochloric acid was cautiously added. The mixture was concentrated to a volume of 500 mL, extracted with ether, the ether extracts washed with sodium bicarbonate and dried over anhydrous magnesium sulfate. Evaporation of the solvent afforded 74 g. of oil used in the next reaction .without further purification.

c. 6-(2-Methoxy-4-chlorophenyl)-5-hexenyl iodide.

A mixture of 74 g. of 5-bromopentyl 2-methoxy-4- chlorophenyl carbinol, 50 g. of sodium iodide and 500 ml. of 2-butanone was heated under reflux for 2.5 days. The reaction mixture was concentrated, water added and the mixture extracted with ether. The ether extracts were dried over anhydrous magnesium sulfate and concentrated to give 84 g. of oil used directly in the next reaction without further purification.

d. 4-[6-(2-Methoxy-4-chlorophenyl)-5-hexenyl]-3,5- heptanedione was prepared from 84 g. of 6-(2- methoxy-4-chlorophenyl)-5-hexenyl iodide and lithium 3.5-heptanedione (from 42 g. of 3,5-heptanedione and 2.6 g. of lithium hydride in 400 ml. of dimethylformamide). The product was chromatographed on silica gel and eluted with ethyl acetate-hexane 1:4 to give 56 g. of oil used directly in the next reaction without further purification.

e. 4-[6-(2-Methoxy-4-chlorophenyl)hexyl]-3,5-heptanedione [1; Ar is 2-MeO-4-ClC H R is H, R and R" are CH CH CO, Y is CH CH CH CH was prepared by hydrogenation of 56 g. of 4-[6-(2-methoxy4- chlorophenyl)-5-hexenyl]-3,5-heptanedione with 6 g.

of 10% palladium-oncarbon catalyst in 340 ml. of benzene. There was thus obtained 56 g. of 4-[6-(2- methoxy-4-chlorophenyl)-hexyl]-3,5-heptanedione in the form of an oil.

f. 4-[6-(2-Hydroxy-4-chlorophenyl)hexyl]-3,5-heptanedione [1; Ar is 2-HO-4-ClC l-l R is H, R and R are CH CH CO, Y is CH CH CH CH 4-[6-(2-Methoxy-4-chlorophenyl)hexyl]-3,5-heptanedione (1.50 g.) in 10 ml. of methylene dichloride was stirred at 60 to -70C. (isopropyl alcohol-Dry Ice bath) while 1.5 g. of boron tribromide in 10 ml. of methylene dichloride was slowly added over a period of minutes. The reaction mixture was removed from the cooling bath, stirred for 90 minutes and poured into 100 ml. of water and 50 ml. of ether. The mixture was stirred for 15 minutes and the ether layer separated and washed with saturated sodium bicarbonate, dried over anhydrous magnesium sulfate and concentrated. The residue was chromatographed on silica gel and eluted with ethyl acetate-hexane 1:4 to give 1.3 g. of 4-[6-( 2- hydroxy-4-chlorophenyl)hexyl]-3,5-heptanedione as an oil. The latter was crystallized from ether-hexane to give a solid with the m.p. 5355C.

EXAMPLE 43 4-[6-(4-Aminosulfonylphenyl)hexyl]-3,5-heptanedione [1; Ar is 4-H NSO C H R is H, R and R" are CH CH CO, Y is CH CH CH CH can be prepared according to Reaction Sequence A starting with paminosulfonylbenzaldehyde and cyclopropyl methyl ketone. The intermediate 4-(3-cyclopropyl-3-oxo-1- propenyl)-benzenesulfonamide has the mp 173C.

A further alternative approach to compounds within the scope of the present invention involves a Friedel- Crafts type reaction between an aromatic compound, ArH, and an omegahaloalkanoic acid halide. The carbonyl group of the resulting aromatic ketone is subsequently removed by reductive methods to give an arylaliphatic halide which is converted to the compounds of the invention by procedurds already described. Example 42 is illustrative of this synthetic approach, as is likewise the following example:

EXAMPLE 44 a. p-Anisyl 5-bromopentyl ketone.

Aluminum chloride (400 g.) was added in portions over a period of 2.5 hours to a cooled (10C.) mixture of 151 g. of 6-bromocaproyl chloride, 78 g. of anisole, 210 ml. of nitrobenzene and 870 ml. of ethylene dichloride. The reaction mixture was stirred for about sixteen hours at room temperature, allowed to stand for another day and then poured into 10 liters of ice-water. The mixture was extracted with ethylene dichloride and the ethylene dichloride extracts concentrated in vacuo. The residue was steam-distilled, and the distilland was extracted with 1.5 liters of benzene. The benzene extracts were washed with water, dried over anhydrous sodium sulfate, decolorized with activated charcoal and concentrated in vacuo. The residue was dissolved in 1.5 liters of benzene, washed with aqueous sodium hydroxide and water, dried over. sodium sulfate and concentrated to an orange oil, which crystallized upon stirring with n-hexane to give161 g. of p'-anis yl S-bromopentyl ketone. m.p. 40-43C.

b. 6-(4-Methoxyphenyl)hexyl bromide.

Zinc (10 mesh, 355 g.) was amalgamated by stirring it in a solution of 35 g. of mercuric chloride in 300 ml. of water and 25 ml. of concentrated hydrochloric acid for 20 minutes. The supernatant was decanted, and to the amalgamated zinc was added 160 g. of p-anisyl 5- bromopentyl ketone, 140 ml. of water, 280 ml. of toluene and ml. of acetic acid. The mixture was warmed to 50C., and 505 ml. of concentrated hydrochloric acid was added in a thin stream over a 20 minute period. The mixture was heated at reflux for six hours, cooled, and the layers were separated. The organic layer was washed with water, sodium bicarbonate solution and again with water, dried over magnesium sulfate and stripped of solvent in vacuo. The residual yellow oil was distilled to give 97 g. of 6-(4-methoxyphenyl)hexy1 bromide, b.p. 134139C. (0.2 mm.).

c. 6-(4-Hydroxyphenyl)hexyl iodide.

A mixture of 16.5 g. of 6-(4-methoxyphenyl)hexyl bromide, 30 ml. of 50% aqueous hydrogen iodide, ml. of acetic acid and a trace of red phosphorus was heated at reflux for four hours. The reflux condenser was occasionally removed to allow methyl iodide to boil away. The reaction mixture was stripped of solvent, 50 ml. of water added and the mixture again stripped of volatiles. The residue was partitioned between water and chloroform, and the latter extracted with water, sodium bisulfite solution and again with water, then dried over anhydrous sodium sulfate and stripped of solvent. The residual oil was used directly in the next reaction.

d. 6-(4-Acetoxyphenyl)hexyl iodide was prepared from 17.1 g. of 6-(4-hydroxyphenyl)hexyl iodide and ml. of acetic anhydride, four days at room temperature and five hours at 90C., and was obtained in the form of a yellow liquid (17.0 g.).

e. 4-[6-(4-Acetoxyphenyl)hexyl]-3,5-heptanedione [1; Ar is 4-CH COOC H R" is H, R and R" are CH CH CO, Y is CH Cl-l CH CH was prepared from 12.0 g. of 6-(4-acetoxyphenyl)hexyl iodide and the lithium salt of 3,5-heptanedione (from 7.7 g. of 3,5-heptanedione), and was obtained as a brown oil (12.0 g.).

f. 4-[6-(4-Hyroxyphenyl)hexyl]-3,5-heptanedione [1; Ar is 4-HOC H R is H, R and R" are CH CH CO, Y is CH CH CH CH I was prepared from 11.5 g. of 4-[6- (4-acetoxyphenyl)hexyl]-3,5-heptanedione, 0.5 g. of potassium carbonate and 200 ml. of anhydrous methanol, 22 hours at room temperature. The product isolated proved to be identical with the compound of Example 28.

1 claim:

1. A compound of the formula 

1. A COMPOUND OF THE FORMULA
 2. 2-(4-Methoxyphenyl)ethyl cyclopropyl carbinol, according to claim
 1. 3. 2-Phenylethyl cyclopropyl carbinol, according to claim
 1. 4. 2-(3,4-Dibenzyloxyphenyl)ethyl cyclopropyl carbinol, according to claim
 1. 5. 2-(4-Chlorophenyl)ethyl cyclopropyl carbinol, according to claim
 1. 6. 2-(p-Tolyl)ethyl cyclopropyl carbinol, according to claim
 1. 7. 2-(4-Benzyloxyphenyl)ethyl cyclopropyl carbinol, according to claim
 1. 